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ABSTRACT 
INVESTIGATION OF BOVINE CONCEPTUS GALECTINS AND THE EFFECT OF 
BOVINE CONCEPTUS SECRETORY PROTEINS ON THE ENDOMETRIAL EPITHELIAL 
TRANSCRIPTOME 
Heather L. Baldwin 
Pregnancy loss in cattle is greatest in the first 30 days of gestation. Near d15 of gestation, 
bovine conceptuses elongate and express LGALS1, an immunosuppressive glycan-binding protein 
believed to be essential for implantation. However, other members of the bovine galectin family, 
including LGALS3, LGALS4, LGALS7, LGALS8, LGALS9 and a galectin-13-like gene 
(LGALS13L), also may be expressed by the elongating conceptus. Therefore, galectin expression 
in elongating, d16 bovine conceptuses and intercaruncular endometrium as well as elongating, d14 
ovine conceptuses and intercaruncular endometrium was assessed by RT-qPCR. Angus heifer and 
Texel ewes underwent estrous cycle synchronization and either inseminated or not bred. On d16 
(heifers) or d14 (ewes) after synchronized estrus (d0), reproductive tracts of pregnant (heifers, 
n=4; ewes, n=3) and cyclic (heifers, n=4; ewes, n=3) animals were removed. Conceptuses and 
intercaruncular endometrial samples were then collected. Conceptuses and intercaruncular 
endometrium samples were individually snap frozen and stored at -80°C until RT-qPCR. Bovine 
and ovine conceptus gene expression was normalized to control genes GAPDH and YWHAZ, and 
endometrial gene expression was normalized to control genes H3F3A and RNF11. A general linear 
model procedure (PROC GLM) in SAS was used to test for differences. For the conceptus data, 
alpha was set at 0.05, and a Tukey’s test was included in the analysis. Conceptus data are presented 
as non-transformed means ± standard deviation (SD) of the mean. Endometrial data are presented 
as non-transformed least square means (LSM) ± standard error of the mean (SEM) and P ≤ 0.05 
was considered significant. In bovine conceptuses, expression of LGALS3 (24.47 ± 6.41) and 
LGALS1 (21.80 ± 2.07) was similar, yet, greater than all other galectins measured (α = 0.05). 
Expression of LGALS8 (1.73 ± 0.27) was 12-fold less than LGALS1, however, LGALS8 
expression was greater than LGALS9 (0.77 ± 0.77), LGALS13L (0.30 ± 0.10), LGALS4 (0.08 ± 
0.01) and LGALS7 (0.02 ± 0.01) (α = 0.05). In bovine intercaruncular endometrium, expression 
of LGALS1, LGALS8, and LGALS9 were greatest. Compared to cyclic heifers, endometrial 
expression of LGALS7 was less (5.80 ± 2.35 and 2.62 ± 2.35; cyclic and pregnant, respectively; 
P ≤ 0.05), while expression of LGALS9 (9.26 ± 2.25 and 24.56 ± 2.25; cyclic and pregnant, 
respectively; P ≤ 0.001) and LGALS3 were greater (2.62 ± 0.52 and 4.40 ± 0.52; cyclic and 
pregnant, respectively; P ≤ 0.05) during pregnancy. In sheep conceptuses, expression of LGALS3 
(4.30 ± 0.78), LGALS1 (1.90 ± 0.25) and LGALS8 (1.68 ± 0.25) were similar. Compared to all 
other galectins measured, LGALS4 (0.20 ± 0.10) had the lowest level of expression (α = 0.05). In 
ovine intercaruncular endometrium, expression of LGALS3, LGALS8, and LGALS15 were 
greatest. Compared to cyclic ewes, expression of LGALS7 was greater in pregnant ewes (0.81 ± 
0.24 and 2.25 ± 0.24; cyclic and pregnant, respectively; P ≤ 0.05) while LGALS4 (3.10 ± 0.38 and 
1.78 ± 0.38; cyclic and pregnant, respectively; P = 0.06) tended to be less during pregnancy and 
LGALS15 tended to be greater during pregnancy (104.30 ± 234.20 and 591.35 ± 234.20, P = 0.07; 
cyclic and pregnant, respectively). In conclusion, elongating bovine and ovine conceptuses express 
various members of the galectin gene family, and select galectin genes are differentially expressed 
in the endometrium during pregnancy. The galectins may have important functions during early 
pregnancy in ruminants. 
Interferon-tau (IFNT), secreted by the elongating bovine conceptus, is the maternal 
recognition of pregnancy signal that suppresses the endometrial luteolytic mechanism by 
modifying expression of genes in specific cell types within the endometrium. The conceptus also 
secretes galectin proteins, specifically galectin-3. This study assessed the effect of IFNT 
(Experiment 1) and LGALS3 (Experiment 2) on bovine endometrial epithelial and fibroblast cell 
transcriptomes when the mid-luteal phase endometrial cells were cultured in a 3D environment. In 
Experiment one, epithelial cells, cultured in Transwell inserts above the fibroblast cells, were 
treated with RPMI media alone (control; n=4) or treatment media (RPMI with 5% FBS and 1% 
ABAM) containing 100 ng of recombinant ovine IFNT (n=3) for 6 h. In Experiment two, cells 
were treated with either RPMI media alone (Control; n=5), pregnant ovine uterine flush fluid, 
theoretically containing INFT, diluted with treatment media 1:1 (n=4), or treatment media (RPMI 
with 5% FBS and 1% ABAM) containing either 100 or 1000 ng of recombinant mouse LGALS3 
(n=5) for 6 h. Total RNA was extracted from both cell types and the transcriptomes were assayed 
by RNA Sequencing and RT-qPCR. Interferon-tau regulated 673 and 83 genes (differentially 
expressed genes or DEGs) in epithelial and fibroblast cells, respectively (P ≤ 0.001; FDR P ≤ 0.05). 
Many of the DEGs identified in the epithelial (205) and fibroblast cells (64) were previously 
reported as IFNT and bovine conceptus-induced DEGs in intact bovine endometrium, including 
well-known ISGs such as ISG15, MX1, MX2, OAS1, and OAS2. Surprisingly, the ZC3HAV1 
gene, which was recently found to be up-regulated in intact bovine endometrium in response to 
the conceptus, was only up-regulated in fibroblast cells despite applying IFNT to the apical surface 
of the epithelial cells in 3D culture. The RNA-Seq analysis of the bovine endometrial cells treated 
with mouse LGALS3 protein resulted in the identification of a single gene, RPL23A, that was 
upregulated in epithelial cells treated with 100 ng of LGALS3 (P ≤ 0.001; FDR P ≤ 0.05). This 
study supports the idea that the 3D culture of bovine endometrial cells may be utilized to study 
early conceptus-maternal crosstalk and identify endometrial cell type-specific responses to the 
conceptus.
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CHAPTER ONE 
LITERATURE REVIEW 
Introduction 
The beef cow/calf industry experiences an annual loss exceeding $1.2 billion, with the 
largest contributing factor being embryonic loss [1]. The highest incidence of pregnancy loss in 
cattle occurs during the embryonic period of gestation, with 40% occurring between day (d) 8 
and 17 [2-4]. The critical period for maternal recognition of pregnancy in cattle is  d15-16 
meaning that, in this time period, the conceptus begins to elongate in structure and secretes a 
substance to communicate with the dam the presence of a pregnancy and to convert the corpus 
luteum (CL) of the estrous cycle to a CL of pregnancy [5]. This secretory protein of the bovine 
trophectoderm is called interferon tau (IFNT) and its presence stimulates the expression of 
interferon-stimulated genes (ISGs) in the endometrium. The endometrial ISGs are considered 
classical or nonclassical and alter the endometrium in preparation for embryonic attachment and 
a successful gestation. Integrin proteins are imperative to attachment as they serve as a ligand for 
extracellular matrix compounds such as fibronectin. Galectins, specifically LGALS3, have been 
shown to interact with integrins to promote antiapoptotic effects during the period of 
implantation in humans and could promote adhesion between the conceptus and endometrium 
[6]. The purpose of this chapter is to review the literature that has contributed to the current 
understanding of the establishment of pregnancy in cattle, the origins of embryonic loss, and the 
possible involvement of LGALS3 during early pregnancy in cattle.  
  
 
2 
The Bovine Estrous Cycle 
The female cow will reach puberty at approximately one year and will begin her 
reproductive cycle. The cycle is referred to as the estrous cycle with the time point of being 
sexually receptive termed “estrus”. Approximately every 21d, a cyclic cow or heifer has the 
chance to become pregnant as the cycle is continuous. The estrous cycle is defined as the period 
from one standing estrus to the next and consists of four stages; proestrus, estrus, metestrus, and 
diestrus [7]. Each estrous cycle can be divided into two phases, the follicular and luteal phases. 
The follicular phase consists of 20% of the estrous cycle and includes both proestrus and estrus. 
Proestrus continues from d17 to d20 of the bovine estrous cycle.  
The beginning of the follicular phase, proestrus, is a result of luteolysis and is driven by 
alternations in the endocrine profile.  Luteolysis marks the beginning of the follicular phase and 
is characterized by the regression of a functional CL due to uterine produced prostaglandin F2 
alpha (PGF). Progesterone (P4) synthesized by the CL develops after the expulsion of an oocyte 
from a follicle and prevents further ovulation. Regression of the CL and subsequent decline of 
circulating P4 allows for gonadotropin-releasing hormone (GnRH) to be released from the 
hypothalamus at a higher amplitude and frequency. Luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) are released from the anterior pituitary. The regulation of the two 
differs as FSH is controlled by negative feedback from inhibin and estrogen, both originating 
from developing follicles. The pulse frequency of LH is controlled by the pulses of GnRH. The 
FSH aids in the development of follicles during proestrus by recruiting a cohort of follicles at the 
start of every follicular wave. Sirois and Fortune (1988) developed a model of bovine follicular 
development and regression by utilizing ultrasonography. Findings suggested that follicular 
development in heifers occurs in wave-like patterns while during each wave, a selected follicle 
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increases in size and asserts dominance on other developing follicles [8]. The selection process 
begins several days in advance to the dominant follicle reaching a preovulation diameter and 
causes regression of other developing follicles. The LH aids in selection which is the further 
development of the dominant follicle.  Increased follicular development results in elevated 
inhibin production from granulosa cells which inhibits further FSH secretion. Following either 
atresia of the developing follicle or ovulation of the oocyte, FSH levels will once again rise to 
initiate another follicular wave [7].  
The production of estradiol (E2), in large concentrations, will result in positive feedback 
on hypothalamic GnRH secretion leading to the preovulatory LH surge. This will trigger 
“standing estrus” meaning the female will become sexual receptive while exhibiting behavioral 
signs such as lordosis, increased movement, and the mounting of other animals. In cattle, estrus, 
which is a result of the LH surge, lasts approximately 15-18 h and ends at ovulation on d0 
marking the end of the follicular phase. Ovulation typically takes place 30 h after the initiation of 
estrus [7].  
 The luteal phase, which begins after ovulation, consists of metestrus and diestrus and 
continues from d0 to d17 of the estrous cycle. Triggered by the preovulatory LH surge, the CL is 
formed from a newly ovulated follicle following luteinization in which the theca interna and 
granulosa cells of the follicle differentiate into small and large luteal cells, respectively. A corpus 
hemorrhagicum (CH) is the structure present immediately after ovulation as a result of the 
rupture of blood vessels as the oocyte complex is released from the follicle. The CH will then 
transition into a functional CL between d3 to d5 of the estrous cycle. Metestrus is characterized 
by the development of a functional CL and the transition to elevated P4 levels and declining E2. 
During this time, the first polar body appears as the oocyte undergoes meiosis. Corpus luteum 
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mass is directly correlated with CL P4 secretions levels as both plateau in the middle of the cycle 
[9]. 
 Thecal and granulosal cells intermix post-ovulation and both contain the capability to 
produce P4. The P4 targets the hypothalamus to suppress GnRH and consequently, LH and FSH, 
by decreasing GnRH receptors located on gonadotrophs in the anterior pituitary. The uterine 
environment is influenced by P4 by aiding in endometrial secretions, termed histotroph, as well 
as restricting contractility of the myometrium. In addition, P4 has the ability to aid in mammary 
gland development. Granulosa cells form large luteal cells while thecal cells form small luteal 
cells. Large luteal cells, as a result of ovulation, possess secretory granules that contain oxytocin 
which will be critical for luteolysis [10].  
 The end of the luteal phase is marked by the occurrence of luteolysis which is induced by 
endometrial PGF. Luteolysis is characterized by a 1-3d regression of the CL resulting in reduced 
blood P4 levels. The PGF originates in the uterine epithelium and travels to the ovary to initiate 
luteolysis through a vascular countercurrent exchange between the uterine vein and ovarian 
artery [11]. This system enables PGF to be transported to the ovary avoiding dilution and 
metabolism that would occur in general circulation [7]. A large portion of PGF secreted by the 
uterine epithelium travels through the utero-ovarian vein and diffuses into the ovarian artery. The 
PGF can initiate apoptosis in luteal cells. As a result, blood P4 concentrations decrease and the 
cycle will transition into a new follicular phase characterized by elevated E2 levels. 
 
Early Bovine Pregnancy 
 Once the physiological and hormonal profiles are precise, the oocyte will ovulate—
allowing the oocyte to migrate to the oviduct. In cattle, past research has shown that the number 
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of ovulations occurring in the right compared to the left ovary is not proportionate with the right 
ovary having a greater ovulation rate [12, 13]. Following ovulation, the infundibulum captures 
the ovulated oocyte and permits the oocyte to travel to the ampulla-isthmic junction (AIJ) for 
possible fertilization. During natural mating, spermatozoa travel from the site of deposition, the 
cranial vagina, through the reproductive tract, to the AIJ [7].  
If fertilization is successful, the presence of both the male and female pronuclei within 
the oocyte’s cytoplasm confirms the existence of an ootid. The male pronucleus is formed once 
the sperm nucleus enters the oocyte’s cytoplasm. The male pronucleus then undergoes 
decondensation allowing the female and male pronuclei fuse together to form a single nucleus. 
The resulting zygote is composed of a single cell [7]. Within 24 h, the single-celled embryo will 
undergo cytokinesis and will cleave into a two-celled embryo with two blastomeres. Blastomere 
cleavages will continue, where the two-cell embryo will cleave into a four-cell embryo followed 
sequential cleavages. It is also important to note that early embryonic development, until d5, 
occurs within the oviduct which has unique secretions in comparison to the uterine horns. The 
oviduct provides an optimal environment for the developing conceptus by providing a specific 
combination of amino acids, energy substrates, and ions [14-16]. Past research has also found 
that the presence of oviductal cells or oviduct conditioned media during culture improves 
embryo viability [17]. 
Near d4, the embryo becomes a morula. Visually, the morula is identified as a solid mass 
of cells which cannot be easily distinguished from one another and quantified. During this time, 
the developing conceptus, which refers to the embryo body and extra-embryonic tissues, is 
transferred from the oviduct into the uterus. Tight junctions between the outer cells of the morula 
aid in the accumulation of fluid within the intercellular spaces inside the morula. Sodium is 
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pumped into the intercellular space and, consequently, water accumulates. Blastocyst formation 
occurs around d7 of pregnancy in cattle. The blastocyst contains a fluid-filled cavity termed a 
blastocoele which consists of two distinct cell populations. One population forms the inner cell 
mass, which will give rise to the body of the developing embryo. The other cell population forms 
the outer layer and is referred to as trophoblast cells which will develop into the chorion of the 
placenta [7]. Lastly, between d7-8 of pregnancy, the blastocyst will hatch from the zona 
pellucida. At this point, the blastocyst is exposed to the uterine secretions. Expulsion of the 
blastocyst is a result of increasing internal pressure due to a combination of early embryonic 
growth, the enzymatic degradation of the zona pellucida, and contraction of the conceptus [7]. 
Once hatched from the zona pellucida, the embryo undergoes dramatic morphological 
change, increasing in size from around 0.15 mm in diameter to over 60 mm in total length due to 
the process of elongation [18]. The bovine embryo will double in length every day between d9-
16 of gestation [19-21]. The sphere-shaped blastocyst will transform into an ovoid conceptus on 
approximately d12. Finally, the conceptus will transition into a tubular structure on 
approximately d13-14 of gestation [22]. The conceptus will span both uterine horns by d18 of 
gestation, later attaching to the uterine surface [7]. Alterations of the uterine environment, 
including histotroph gene expression, are mediated by an increased concentration of P4 which 
promotes rapid conceptus growth [23]. Uterine histotroph consists of enzymes, growth factors, 
cytokines, hormones, transport proteins, and other substances [20, 24-27]. During this time, the 
extraembryonic membranes of the pre-attachment embryo rapidly develop and are comprised of 
the yolk sac, chorion, amnion, and allantosis. Bovine pre-attachment blastocysts are 
characterized by having a filamentous and thread-like structure near d16-17 [22].  
As the development of the embryo progresses beyond the blastocyst stage, a dependency 
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on the maternal uterine environment develops. Bovine blastocysts can be produced by in vitro 
fertilization (IVF) technology; however, the uterine environment is essential for the elongation of 
the developing conceptus [28, 29]. Ex vivo, outside of the uterus, ruminant blastocysts are unable 
to elongate as histotroph from endometrial glands is essential for this process [30, 31]. Gray and 
coauthors (2002) utilized uterine gland knockout (UGKO) sheep to investigate the role of 
endometrial secretions on elongation. The UGKO ewes were generated by utilizing synthetic 
progestin which results in the lack of uterine glands after postnatal chronic exposure in ewe 
lambs [31]. In sheep, conceptuses normally elongate around d14 of gestation. Day 14 
conceptuses from UGKO ewes were observed to be fragmented, growth-retarded, and tubular. In 
addition, it was concluded that development was interrupted in embryos from knock-out gland 
ewes due to lack of endometrial glands opposed to alterations in the expression of molecules that 
impact adhesiveness of the luminal epithelium [30].  
Maternal Recognition of Pregnancy  
Reciprocal communication takes place between the embryo and the uterine environment. 
Increased levels of steroid hormones, P4 and E2, affects uterine gland gene expression 
promoting elongation and growth of the conceptus. Progesterone also controls the expression of 
genes that aid in uterine receptivity to the conceptus. Uterine receptivity is essential for 
embryonic growth, development, and attachment [20, 32]. In addition, the conceptus will release 
proteins, steroids, and other factors that affect endometrial cell gene expression. Conceptus 
IFNT, a cytokine, causes modifications to endometrial PGF production that disrupts luteolysis 
allowing continuous P4 synthesis [33]. This process is termed maternal recognition of pregnancy 
and must occur between d15-16 of gestation for pregnancy to successfully continue. Trophoblast 
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cells are characterized into two groups: trophoblast mononucleate cells (TMC) and trophoblast 
binucleate cells (BNC) [34]. The TMCs are responsible for the secretion of the maternal 
recognition of pregnancy factor in ruminants. IFNT will then inhibit the transcription of the 
oxytocin receptor (OTR) in the LE/sGE of the uterus by first silencing estrogen receptor alpha 
(ESR1) expression [33, 35]. In the absence of oxytocin, luteolytic pulses of PGF cannot occur, 
thus prolonging the CL lifespan. Comparing pregnant to cyclic animals, basal levels of PGF and 
prostaglandin E2 (PGE2) in pregnant animals remain elevated due to continued uterine 
prostaglandin synthase 2 (PTGS2) expression [35]. The silencing of ESR1 by IFNT disables E2 
from inducing endometrial epithelial progesterone receptor (PGR) transcription which allows 
stromal cells expressing PGR to regulate expression of ISGs [36].  
Ulbrich et al. (2009) quantified prostaglandins (PGs) in the uteri of preimplantation 
pregnancy stage heifers in comparison to non-pregnant control heifers. It was found the presence 
of an embryo influenced the intrauterine environment of d15 pregnant heifers to consist of higher 
concentrations of prostaglandin I2 (PGI2) and secondly, PGF, both of which were greater than 
PGE2 [37]. Overall, clear evidence was found that the ratio of PGF/PGE2 was not altered 
between cyclic and pregnant heifers as the embryo contributes to the PG environment. Likely, 
PGI2 plays a role in the permeability of maternal vasculature. Both PGE2 and PGI2 have been 
found to be critical during the regulation of implantation and decidualization in other species 
including humans and mice [38, 39].  
Interferon-tau is a type I interferon. Type I interferons are important in most viral 
defenses.  Type I interferons bind the interferon alpha receptor (IFNAR) to signal a response 
biologically while the single Type II interferon family member, interferon gamma (IFNG) binds 
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interferon gamma receptor (IFNGR) [40]. The pregnancy recognition signal, IFNT, will 
differentially impact gene expression of cells in the luminal epithelium (LE), deep glandular 
epithelium (dGE), surface glandular epithelium (sGE), and stroma [36, 41]. The ISGs and are 
suggested to play various roles in the differentiation of the endometrium in preparation for 
pregnancy. There are two distinct classifications of ISGs, classical and non-classical, which are 
spatially stimulated by IFNT within the stroma/dGE and LE/sGE, respectively [42, 43]. Type I 
and II IFNs initiate the expression of classical ISGs through stimulation of janus-associated 
kinases and signal transducers and activators of transcription (Jak-STAT) pathways resulting in 
phosphorylation of their respective receptors activating STAT. 
 There is a greater understanding of IFNT mediated ISG effects in the ovine endometrium 
compared to cattle. The working hypothesis is as follows: conceptus-derived IFNT binds its 
receptor, IFNAR, in the LE/sGE. There, interferon regulatory factor 2 (IRF2), which is a 
transcriptional repressor, is up-regulated. The IRF2 inhibits ISGs which are considered 
classically activated such as STAT1, STAT2, interferon regulatory factor 9 (IRF9), beta-2 
microglobulin (B2M), ISG15 ubiquitin-like modifier (ISG15), major histocompatibility complex 
(MHC), and oligoadenylate synthetase (OAS). However, IFNT is able to activate genes in the 
non-classical category of ISGs such as cystatin-3 (CST3), cathepsin-L (CTSL), and galectin-15 
(LGALS15) in the LE/sGE of sheep through a currently unknown biological cell-signaling 
pathway [42]. Inversely, dGE and stromal cells lack expression of IRF2 resulting in activation of 
JAK1 and tyrosine kinase-2 (Tyk2), and consequently, STAT2. Once STAT2 is phosphorylated, 
STAT1 is able to become phosphorylated as well. With STAT1 and 2 activation, interferon-
stimulated gene factor-3 (ISGF3) and interferon regulatory factor-1 (IRF1) transcription factors 
become activated allowing for the transactivation of classical ISGs [42, 44]. The LE and sGE 
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may lack classical ISG expression during early pregnancy as a method of defense against the 
immune rejection of the partially genetically dissimilar conceptus [45, 46]. 
The BNCs of the trophoblast appear between d18 and 20 of gestation in cattle and 
migrate from the chorionic tissue to the maternal endometrium where they secrete factors such as 
placental lactogen (PL) and pregnancy-associated glycoproteins (PAGs). The BNCs also secret 
PG, along with estrogens, during preimplantation development. The BNC derived PAGs are 
believed to play a role in the regulation of placentation, mammogenesis, steroidogenesis, and 
immune function [47-50]. Other vital trophoblastic secreted molecules include Bcl-2-related 
protein A1 (BCL2A1) which is BNC derived and is an imperative anti-apoptotic factor involved 
in cell maintenance [51]. Bovine TMCs and BNCs, along with maternal tissues, have been found 
to contain secreted protein of Ly-6 domain 1 (SOLD1) which plays various roles including 
reconstruction of the post-partum uterus, fetal and placental growth, and placental expulsion. 
Further, investigators found SOLD1 is involved in trophoblast cell migration and induced 
invasion [52, 53]. 
Bovine Embryonic Attachment 
Implantation of the developing ruminant conceptus is rather non-invasive and consists of 
the process by which the fetal membranes attach to the maternal endometrial epithelium. Bovine 
embryonic attachment occurs near d21 of gestation, a time when the allantois formation becomes 
apparent macroscopically [54, 55]. Post-elongation, the conceptus will begin to attach to the LE 
while trophoblastic projections become incorporated into the openings of the maternal uterine 
glands [56]. The driving force of preparation of the endometrium for attachment of the 
developing conceptus is P4 [35, 57]. Implantation is accompanied by increased production of 
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secretions by the epithelial cells within the uterine lumen.  
Past research in cattle and sheep has found certain histotroph components to be of 
significant importance during the attachment phase [30, 42]. Successful implantation requires a 
normally developed blastocyst, a receptive endometrium, and corresponding communication 
between the two—a process which is orchestrated by various cytokines and growth factors such 
as interleukin-10 (IL-10), leukemia inhibitory factor (LIF), colony-stimulating factors (CSF), 
interleukin-1 (IL-1), and insulin-like growth factor 1 (IGF-1) [58, 59]. Members of the family of 
proteins called integrins (ITGs) are imperative for successful implantation [60]. Integrins serve 
as a receptor for fibronectin, vitronectin, laminin, collagen type IV, and osteopontin—all of 
which compose the extracellular matrix [60-62]. Interferon gamma-inducible protein 10 (IP10), 
LGALS15, and insulin-like growth factor-binding protein 1 (IGFBP1), all of which are 
components of the uterine histotroph, have been described to induce ITGs during the attachment 
of the trophectoderm to uterine tissue [61, 63-65].  
Growth factors that are endometrial and/or conceptus derived, such as tumor necrosis 
factor alpha (TNF), initiate direct communication between the maternal and trophoblastic cells. 
The pro-inflammatory cytokine, TNF, is involved in various cellular activities including cell 
differentiation, survival, and tissue homeostasis. The TNF has the capability to bind two 
distinct receptors, TNF receptor 1(TNFR1) or TNF receptor 2 (TNFR2), which can have 
dissimilar functions. Interestingly, TNFR1 activation is involved in cell apoptosis while TNFR2 
can be involved in either cell proliferation or apoptosis. Along with TNFR2, TNF protein and 
mRNA have been found to be expressed in pregnant and cyclic endometria of cattle and 
expressed in endometrial and placental tissues of other species including humans during early 
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and late gestation [66, 67]. It is speculated that nuclear factor kappa B (NFB), a transcription 
factor that is activated by TNF, is down-regulated in the blastocyst to suppress immune 
function during blastocyst formation. The endometrium is believed to regulate TNF 
concentrations via controlling the secretion of TNF into the histotroph as well as regulating the 
embryo’s transcription of both TNF and TNFR2 mRNA [67]. TNF has been shown to 
stimulate PGF synthesis in endometrial stromal cells and IFNT has been shown to have an 
inhibitory effect on TNF [68]. 
Preimplantation factor (PIF) is a peptide found to be secreted by murine, human, and 
bovine embryos, as well as placental tissue. Additionally, PIF has been found to be in human 
maternal general circulation [69, 70]. Trophoblastic PIF is expressed largely in the first and 
second trimesters and may be an indication of viable embryos that are in vitro produced by 
determining culture medium levels [71]. Human decidua cells cultured with PIF exhibited a role 
in immune regulation, adhesion, and regulation of apoptotic processes [72].  
Early Pregnancy Loss in Cattle 
Embryonic mortality is defined as the loss of pregnancy from the time of conception to 
d45 of gestation in cattle with early embryonic loss occurring from d0-27 and late embryonic 
loss occurring from d28-45 of gestation [73]. Most pregnancy losses occur in the first 50 days of 
gestation with losses before d20 attributing to 75% of all reproductive failures [74, 75]. Revenue 
from both dairy and beef farms depend on reproductive success. Therefore, it is important to 
address the causes of early embryonic loss to minimize financial loss. Reported fertilization rates 
in beef cattle are high, with values ranging from 93-96% when insemination occurs at the proper 
time in relation to ovulation [76-78].  Most reproductive failure following insemination occurs 
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post-fertilization. Methods known to minimize loss during the first eight days of pregnancy 
include alleviating heat stress, inflammatory diseases, body condition loss, and by increasing 
preovulatory follicular development progesterone levels as this time period comprises 20-50% of 
all embryonic loss [18]. Researchers addressed the role of a persistent follicle (PF) on early 
embryonic loss and found evidence that an oocyte from a PF is capable of becoming fertilized 
but exhibited a disability to grow into a 16-cell stage embryo [76]. The reduction in fertility is 
due to biochemical and morphological alterations that take place within a follicle that remains 
dominant for an extended period of time [75]. Along with an altered endocrine profile, studies 
have shown the occurrence of PF in cattle is accompanied by altered follicular steroid and 
gonadotropin receptor expression [79-81]. 
Galectin-3 
 Galectin-3 (LGALS3) is located on chromosome 10 in cattle and is a member of a large 
family of -galactoside-binding animal lectins that have numerous physiological functions. 
Lectins bind carbohydrates and result in cell agglutination while playing vital roles in pathogen 
defense, cell trafficking, and immune regulation [82, 83]. Currently, 15 members have been 
identified in mammals [84]. Galectins are ancient members of a lectin family which are 
characterized by having conserved amino acid sequences with at least one carbohydrate 
recognition domain (CRD) and the ability to recognize -galactoside structures located on cell 
surface glycoconjugates [85, 86]. Galectin family members have been categorized into three 
groups based on the number and organization of CRDs present: 1) the prototype, consisting of a 
single CRD, 2) the chimera type, whose only member is LGALS3 and consists of one CRD 
along with a non-lectin domain, and 3) the tandem repeat which consists of a short peptide linked 
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by two CRDs [82, 87, 88].  
Galectin-3 is a 29 to 35 kDa protein and consists of a 110-130 amino acid N-terminal 
domain connected to glycine and proline-rich repeats, along with a single C-terminal CRD [87]. 
A conformational change occurs when LGALS3 or its CRD interact with carbohydrate ligands 
leading to rearrangement of the backbone loops located nearby its binding site. Multiple ligands 
of LGALS3 have been identified and include extracellular glycoproteins and glycolipids [89, 
90]. N-terminal domain and CRD have been shown to interact in the formation of LGALS3 
multimers as LGALS3 possess bivalent and multivalent binding properties [87, 91]. It is also 
unique in that it is the only chimera-type galectin found in vertebrates and has been discovered in 
various cell types including tumor cells, macrophages, activated T cells, epithelial cells, and 
fibroblasts. The localization of LGALS3 protein is dependent on the cell type as LGALS3 
protein has been reported to be found in the cytoplasm or secreted through non-classical 
pathways [87, 92]. Galectin-3 does not contain an N-terminal signal sequence and becomes 
externalized through an endoplasmic reticulum-Golgi complex independent mechanism [93].  
Also, LGALS3 may translocate to the nucleus or become secreted via a non-classical pathway of 
secretion following its cytoplasmic ribosomal synthesis. [94-96]. Intracellularly, LGALS3 has 
been shown to interact with nuclear and cytoplasmic proteins leading to the modulation of 
signaling pathways [86]. In addition, intracellular LGALS3 mediates anti-apoptotic effects by 
inhibiting apoptosis caused by nitrogen-free radicals [97]. Extracellular LGALS3 binds to 
oligosaccharides located on the surface of cells and promotes apoptosis by the release of 
cytochrome c and caspase-3 activation [98].  
Galectin-3 has functions in the regulation of the immune response and may be involved 
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in the development of cancer and heart disease. Galectin-3 is also involved in various biological 
processes including cell adhesion, cell activation, chemoattraction, proliferation, cellular 
differentiation, and apoptosis [84, 87, 99]. Regarding immunology, LGALS3 is a regulator of 
inflammation and is secreted by macrophages, monocytes, dendritic cells, eosinophils, mast 
cells, natural killer cells, and both activated B and T cells [89, 100]. 
Cancer researchers have determined that LGALS3 promotes tumor cells growth in certain 
cancer types while promoting anti-apoptotic effects on tumor cells in various other cancers [101]. 
Contrarily, in cancers such as breast, non-melanoma skin, prostate, endometrial, and leukemia 
cancers, LGALS3 exerts tumor suppression effects on cancerous cells [102]. In the case of 
endometrial and breast cancers, a down-regulation of LGALS3 is associated with amplified 
aggressiveness while in pancreatic cancer, LGALS3 up-regulation is linked to cancer cell 
proliferation and invasion [102-104]. A study utilizing LGALS3 small interfering RNA (siRNA) 
found the knockdown resulted in a reduction in migration of cancer cells, invasion, cell 
proliferation, anchorage-independent colony formation, and tumor growth in mice with prostate 
cancer [105]. Signaling pathways of LGALS3 vary between cancers as well. Research has shown 
in cases of melanoma and gastric cancer, LGALS3 promotes tumor growth through the up-
regulation of metalloproteinase-1 (MMP-1) and by the regulation of mitogen-activated protein 
kinases (MAPK) pathway in lung cancer [41, 106, 107]. In human breast cancer, LGALS3 has 
been shown to activate wingless-related integration site (Wnt) signaling, which is characterized 
by nuclear accumulation of β-catenin—a major component of the Wnt pathway [108-110]. In 
human colon cancer cells, via the phosphatidylinositol 3-kinase (PI3K) and protein kinase B 
(AKT) pathway, LGALS3 regulates glycogen synthase kinase-3β (GSK-3β) phosphorylation 
leading to the degradation of β-catenin [108]. 
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 Expression of LGALS3 in myocardial cells of healthy humans and rodents is low, 
however, LGALS3 protein up-regulation has been observed during cardiac stressors leading to 
cardiac fibrosis and ultimately, heart failure [111]. Expression levels are found to correlate with 
progression and severity of cardiac damage, therefore, levels are utilized as a biomarker for heart 
failure [112]. It is hypothesized that LGALS3 expression in heart failure is triggered hormonally 
by aldosterone or angiotensin II. Also, the combination of LGALS3 and aldosterone or 
angiotensin II instigates sclerosis, fibrosis, and hypertrophy of the renal system, cardiac tissue, as 
well as vascular tissue [113, 114]. Cardiac fibroblast proliferation is triggered by LGALS3 which 
induces detrimental collagen I deposition that will impact the diastolic and systolic functions of 
the heart [99].  
Galectin-3 in Reproduction 
 Recently, LGALS3 was identified to play an important part in the preparation of the 
endometrium for implantation with a presence in the endometrium and trophoblast cells. Given 
the resemblances of tumor invasion and the migration of trophoblast cells, investigators have 
addressed the possible roles of LGALS3 at the maternal-fetal interface regarding implantation 
[115, 116]. Previous work suggests LGALS3 expression is regulated by different mechanisms in 
placental tissues compared to uterine expression. After conducting immunohistochemistry (IHC) 
studies on pregnant murine uteroplacental tissue samples, it was concluded that LGALS3 is 
synthesized by all cell types within the murine uteroplacental samples. Levels of LGALS3 
mRNA remained constant in murine uterine tissues until d12 of gestation and declined thereafter 
until parturition. Interestingly, in placental tissues, LGALS3 mRNA levels remained constant 
after d12 of gestation until term [115]. In bovine tissues, LGALS3 protein has been identified in 
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the cervix, oviduct, uterus, atretic follicles, and CL [117]. Specifically, in the nonpregnant 
bovine uterus, LGALS3 has been localized via IHC in some epithelial cells as well as 
macrophages located in the submucosa but were absent in endometrial glands [117]. In the 
bovine CL, LGALS3 expression was elevated at the regressed state in comparison to all other 
luteal stages and was localized on steroidogenic cells in the CL [118]. 
 Successful implantation or attachment requires tight regulation of endometrial receptivity 
preparations including cellular proliferation proceeded by differentiation [119]. The expression 
of cell surface molecules alters as uterine receptivity develops though not a lot is known about 
molecular interactions occurring at the maternal-fetal interface. Galectins have been found to 
increase cell-adhesion by associating surface glycoproteins on opposing cells in addition to 
strengthening other intercellular adhesion molecules [120].  
The Role of Galectin-3 in Apoptosis 
A study utilizing the human epithelial endometrial derived cell line, RL95-2, addressed 
the effects of intracellular LGALS3 on apoptosis. Apoptosis inducers were utilized to determine 
if expression levels of LGALS3 were altered and it was found LGALS3 expression was increased 
in apoptotic conditions [6]. To address whether the upregulation of LGALS3 was pro-apoptotic, a 
siRNA technique was used to silence LGALS3 in RL95-2 epithelial cells. It was observed that in 
the presence of apoptosis inducers, RL95-2 cells with LGALS3 siRNA were more sensitive to the 
induced apoptosis. It was then suggested that the upregulation of LGALS3 during the time of 
implantation in the human menstrual cycle may result in endometrial antiapoptotic effects [6]. In 
addition, LGALS3 was postulated to be an antiapoptotic factor under P4 and E2 regulation. When 
RL95-2 cells were treated with LGALS3 siRNA, the previously exhibited antiapoptotic roles of 
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P4 and E2 were eliminated. Through an underdetermined relationship, P4 and E2 are proposed to 
indirectly or directly promote LGALS3 expression and, consequently, antiapoptotic effects [6]. 
Further, when studying women with endometriosis, decreased endometrial LGALS3 expression 
was observed while P4 and E2 regulated LGALS3 expression in endometrial epithelial cells. 
Ultimately, the lack of LGALS3 expression was thought to have caused resistance to a P4 uterine 
environment leading to endometriosis-related infertility [121]. 
Integrins are significant during the preimplantation period as they play a major role in 
cell adhesion. Via surface interactions with extracellular matrix ligands, integrins have been 
found to play a role in the embryo-endometrium cross talk in humans [122, 123]. Extracellular 
LGALS3 binds to β-1 integrin and induces apoptosis. Bovine luteal cells express β-1 integrin and 
contain glycans to which LGALS3 will bind. Hashiba et al. (2014) found that PGF stimulated 
secreted LGALS3 from cultured luteal steroidogenic cells and LGALS3 plays a structural 
luteolytic role through binding to β-1 integrin [118]. Induced by LGALS3, a form of 
programmed cell death, termed anoikis, occurs in the bovine luteal steroidogenic cells due to 
inhibition of β-1 integrin-extracellular matrix binding [118, 124, 125].  
3D Cell Culture 
 In the past, two-dimensional (2D) monoculture techniques have been utilized to 
investigate cellular processes of bovine epithelial and fibroblast cells [126]. To better simulate 
the columnar arrangement of epithelial cells in vivo, a three-dimensional (3D) culture allows 
epithelial cells to maintain a physiological polarity in vitro due to tight junctions unlike the 
traditional 2D cell culture techniques [127, 128]. Tight junctions are imperative to epithelial 
cellular functions because the passage of ions and molecules paracellularly is regulated by tight 
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junctions [129, 130]. The 3D transwell culture system enables the coculture of two cells types 
which physiologically interact in vivo. Transepithelial electrical resistance (TEER), a 
measurement which reflects epithelial integrity, can be measured via an epithelial volt-ohm 
meter [127]. The following studies investigated the expression of galectins in bovine conceptuses 
and in the endometrium. Further, the effect of IFNT and LGALS3 on the endometrial epithelium 
and fibroblast transcriptomes in a 3D cell culture system was investigated.  
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CHAPTER TWO 
GALECTIN GENE EXPRESSION IN BOVINE AND OVINE ELONGATING 
CONCEPTUSES AND PREGNANT AND CYCLIC ENDOMETRIUM 
 
ABSTRACT 
 
Pregnancy loss in cattle is greatest in the first 30 days of gestation. Near d15 of gestation, 
bovine conceptuses elongate and express LGALS1, an immunosuppressive glycan-binding 
protein believed to be essential for implantation. However, other members of the bovine galectin 
family, including LGALS3, LGALS4, LGALS7, LGALS8, LGALS9 and a galectin-13-like gene 
(LGALS13L), also may be expressed by the elongating conceptus. Therefore, galectin expression 
in elongating, d16 bovine conceptuses and intercaruncular endometrium as well as elongating, 
d14 ovine conceptuses and intercaruncular endometrium was assessed by RT-qPCR. Angus 
heifer and Texel ewes underwent estrous cycle synchronization and either inseminated or not 
bred. On d16 (heifers) or d14 (ewes) after synchronized estrus (d0), reproductive tracts of 
pregnant (heifers, n=4; ewes, n=3) and cyclic (heifers, n=4; ewes, n=3) animals were removed. 
Conceptuses and intercaruncular endometrial samples were then collected. Conceptuses and 
intercaruncular endometrium samples were individually snap frozen and stored at -80°C until 
RT-qPCR. Bovine and ovine conceptus gene expression was normalized to control genes 
GAPDH and YWHAZ, and endometrial gene expression was normalized to control genes H3F3A 
and RNF11. A general linear model procedure (PROC GLM) in SAS was used to test for 
differences. For the conceptus data, alpha was set at 0.05, and a Tukey’s test was included in the 
analysis. Conceptus data are presented as non-transformed means ± standard deviation (SD) of 
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the mean. Endometrial data are presented as non-transformed least square means (LSM) ± 
standard error of the mean (SEM) and P ≤ 0.05 was considered significant. In bovine 
conceptuses, expression of LGALS3 (24.47 ± 6.41) and LGALS1 (21.80 ± 2.07) was similar, yet, 
greater than all other galectins measured (α = 0.05). Expression of LGALS8 (1.73 ± 0.27) was 
12-fold less than LGALS1, however, LGALS8 expression was greater than LGALS9 (0.77 ± 0.77), 
LGALS13L (0.30 ± 0.10), LGALS4 (0.08 ± 0.01) and LGALS7 (0.02 ± 0.01) (α = 0.05). In bovine 
intercaruncular endometrium, expression of LGALS1, LGALS8, and LGALS9 were greatest. 
Compared to cyclic heifers, endometrial expression of LGALS7 was less (5.80 ± 2.35 and 2.62 ± 
2.35; cyclic and pregnant, respectively; P ≤ 0.05), while expression of LGALS9 (9.26 ± 2.25 and 
24.56 ± 2.25; cyclic and pregnant, respectively; P ≤ 0.001) and LGALS3 were greater (2.62 ± 
0.52 and 4.40 ± 0.52; cyclic and pregnant, respectively; P ≤ 0.05) during pregnancy. In sheep 
conceptuses, expression of LGALS3 (4.30 ± 0.78), LGALS1 (1.90 ± 0.25) and LGALS8 (1.68 ± 
0.25) were similar. Compared to all other galectins measured, LGALS4 (0.20 ± 0.10) had the 
lowest level of expression (α = 0.05). In ovine intercaruncular endometrium, expression of 
LGALS3, LGALS8, and LGALS15 were greatest. Compared to cyclic ewes, expression of 
LGALS7 was greater in pregnant ewes (0.81 ± 0.24 and 2.25 ± 0.24; cyclic and pregnant, 
respectively; P ≤ 0.05) while LGALS4 (3.10 ± 0.38 and 1.78 ± 0.38; cyclic and pregnant, 
respectively; P = 0.06) tended to be less during pregnancy and LGALS15 tended to be greater 
during pregnancy (104.30 ± 234.20 and 591.35 ± 234.20, P = 0.07; cyclic and pregnant, 
respectively). In conclusion, elongating bovine and ovine conceptuses express various members 
of the galectin gene family, and select galectin genes are differentially expressed in the 
endometrium during pregnancy. The galectins may have important functions during early 
pregnancy in ruminants. 
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INTRODUCTION 
 
Galectins are a large family of -galactoside-binding animal lectins that have numerous 
physiological functions. Lectins bind carbohydrates and result in cell agglutination while playing 
vital roles in pathogen defense, cell trafficking, and immune regulation [82, 83]. Currently, 15 
members of the galectin family have been identified in mammals [84]. Galectins are ancient 
members of a lectin family, which are characterized by having conserved amino acid sequences 
with at least one CRD and the ability to recognize -galactoside structures on cell surface 
glycoconjugates [85, 86]. Galectins also interact with proteins independently of carbohydrates—
acting in an autocrine manner to inhibit cell growth and division [133]. The galectin family of 
proteins has been shown to play a crucial role in regulating tumor and placental angiogenesis 
[134, 135]. In addition, galectins play a large role immunologically in inflammation, adaptive 
and innate immune responses, and immune tolerance [136, 137]. Elongating bovine conceptuses 
express galectin-1 (LGALS1) which has also been associated with the viability of d7 bovine 
blastocysts. Expression of LGALS1 was found to be elevated in in-vivo produced blastocysts 
compared to less viable in-vitro produced d7 bovine blastocysts [138]. Further, the endometrium 
of sheep produces LGALS15 after d10 of gestation to aid in trophectoderm migration and 
attachment. However, LGALS15 is not found in cattle [64]. 
Galectin family members have been categorized into three groups based on the number and 
organization of CRDs present.  The prototype group, consisting of a single CRD, includes 
LGALS1, 2, 5, 7, 10, 11, 13, 14, and 15. The chimera type group, whose only member is 
LGALS3, consists of one CRD along with a non-lectin domain. The tandem repeat group, which 
include a short peptide linked by two CRDs, members include LGALS4, 6, 8, 9, and 12 [82, 87, 
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88]. According to published transcriptomic and proteomic data and published bovine genome 
sequences in NCBI, cattle have genes encoding LGALS1, galectin-2 (LGALS2), LGALS3, 
galectin-4 (LGALS4), galectin-7 (LGALS7), galectin 7B (LGALS7B), galectin-8 (LGALS8), 
LGALS9, galectin-12 (LGALS12), and galectin-13Like (LGALS13L) while the ovine genome 
contains galectin genes for LGALS1, LGALS2, LGALS3, LGALS4, LGALS7, LGALS8, LGALS9, 
LGALS12, galectin-14 (LGALS14), and LGALS15 (https://www.ncbi.nlm.nih.gov/genbank/ 
version 19.12.2017, 23.30.00). 
Alterations of the uterine environment, including histotroph gene expression, are 
mediated by an increased concentration of P4 which promotes rapid conceptus growth [23]. 
Uterine histotroph consists of enzymes, growth factors, cytokines, hormones, transport proteins, 
and other substances [20, 24-27]. The bovine conceptus will double in length every day between 
d9-16 of gestation [19-21]. Bovine pre-attachment blastocysts are characterized by having a 
filamentous and thread-like structure, which arises around d16-17 [22]. The conceptus will span 
both uterine horns by d18 of gestation, later attaching to the uterine surface [7]. Early 
conceptuses secrete factors, including proteins and steroids, that aid in alteration of the maternal 
endometrium [131, 132].   
The aim of this study was to characterize galectin gene expression in the early bovine and 
ovine conceptus during the elongation phase of development as well as to characterize their 
expression in the endometrium in response to the conceptus. 
 
 
  
 
24 
MATERIALS AND METHODS 
Animals and Tissue Collection 
All procedures were in compliance with the Guide for the Care and Use of Agricultural 
Animals in Research and Teaching and approved by the West Virginia University Institutional 
Animal Care and Use Committee (WVU IACUC). All animals were housed at the West Virginia 
University Animal Science Farm (Morgantown, WV). Angus and Hereford heifers were 
subjected to a Co-Sync + 7d controlled intravaginal drug releasing device (CIDR; Zoetis, 
Parsippany-Troy Hills, NJ) protocol to synchronize estrus [139]. Approximately 52-56 h post 
CIDR removal, heifers received GnRH and were either inseminated (n=4) with semen from an 
Angus bull or not bred (n=4). Estrus was synchronized in Texel ewes using a 5d CIDR program 
[140]. Ewes were then either placed with a Texel ram to be naturally bred (n=3) or not placed 
with the ram (n=3) 24 hours after CIDR removal. To obtain pregnant and cyclic reproductive 
tissues, heifers and ewes were slaughtered at a local abattoir 16 and 14 days later, respectively. 
Within 45 min, all reproductive tracts were flushed using 20 mL of 1X PBS (Thermo Fisher, 
Waltham, MA). Conceptuses were then collected and intercaruncular endometrial samples were 
collected from the uterine horn ipsilateral to the CL. All tissue samples were immediately snap-
frozen and stored at -80˚C until RNA extraction.  
 
RNA Extraction  
RNA was extracted from bovine (n=4) and ovine (n=3) conceptuses and endometrium. A 
5-mm steel bead (Qiagen, Hilden, Germany), washed in RNaseZap (Thermo Fisher), was placed 
in each screw-cap tube containing the conceptus along with 350 µL of lysis buffer. Screw-cap 
tubes were placed in a Mini-Beadbeater-24 (Biospec Products, Bartlesville, Oklahoma) and 
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homogenized for 30 s at maximum speed. The lysate was transferred to a homogenizer spin 
column (Omega Bio-Tek, Inc., Norcross, GA) along with an additional 350 µL of lysis buffer. 
Columns were centrifuged for 2 min at maximum speed. The RNA was extracted from the lysate 
according to recommendations from the manufacturer of the E.Z.N.A. DNA/RNA kit (Omega 
Bio-Tek, Inc.).  
Intercaruncular endometrium samples (<50 mg) were placed in a screw-cap tube 
containing a single steel bead (Qiagen) and 1.0 mL of Trizol (Thermo Fisher). Screw-cap tubes 
were then placed in a Mini-Beadbeater-24 (Biospec Products) and homogenized for 2 min at 
maximum speed. After centrifuging, 0.1 mL of chloroform was added to the lysate, vigorously 
shaken, and allowed to rest for 3 min. Samples were then transferred to a precooled centrifuge 
(4°C) and spun at 12,000 x g for 15 min. The aqueous supernatant from the tubes was removed, 
combined with 1.5 x volumes of 100% ethanol, and gently mixed. The E.Z.N.A Total RNA Kit 1 
(Omega Bio-Tek, Inc.) was then used to extract RNA following the manufacturer's 
recommendations. The concentration of RNA and integrity was determined using NanoDrop 
(NanoDrop ND-1000, NanoDrop Technologies, Wilmington, DE) and Bioanalyzer (2100 
Bioanalyzer, Agilent Technologies, Santa Clara, CA). The RNA was stored at -80°C until cDNA 
was synthesized.  
 
Reverse Transcription and RT-qPCR 
Following the manufacturer's recommendations, cDNA was synthesized using a High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Briefly, 500 
ng of RNA and nuclease-free water was added to 10 µL of master mix to reach a total volume of 
20 µL. No-reverse transcriptase control samples were prepared. Following a 2 h cDNA synthesis 
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at 37˚C, 5 µL of each sample was pooled and the remaining cDNA was diluted 1:20 using 
nuclease-free water. Pooled cDNA was used to generate 7 standards (1:4 serial dilutions). 
Standards were used to calculate primer efficiencies (E = [10(-1/slope)-1). The slope is a plot of 
observed Ct values versus the 7 standard serial dilutions. Percent efficiency was then obtained by 
dividing E by 2 and multiplying by 100.  
Quantitative real-time PCR was utilized to measure the expression of galectin genes. The 
CFX96 Real-Time PCR machine (Bio-Rad Laboratories, Hercules, CA) was used to perform 
RT-qPCR reactions. All primers were designed using Primer3Plus (Version 2.4.2) unless 
otherwise noted. Primer sets for bovine and ovine cDNA were identical unless otherwise noted. 
Sample RT-qPCR reactions were carried out in 20 L reactions in duplicate [10 L of SYBR 
Green Master Mix (Catalog Number: A25743; Applied Biosystems), 1.2 L of forward and 
reverse primer mix (1 µM final concentration), 2.6 L nuclease-free water, and 5L of cDNA 
template (6.6 ng RNA equivalent)]. RT-qPCR reaction of no-reverse transcriptase controls and 
no-template controls were included. Thermo-cycling conditions were as follows: 50°C for 2 min, 
95°C for 2 min, which was followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. A 
disassociation analysis was included for each primer set and the presence of a single, sharp peak 
was confirmed. 
The qbase+ package (Biogazelle; Zwijnaarde, Belgium) was used to select reference 
genes. Average RT-qPCR Ct values were imported into qbase+ software, which was used to 
analyze real-time data and generate the normalized relative quantity (NRQ) of genes of interest 
using a generalized delta-delta quantification cycle method (ΔΔCq; also known as ΔΔ cycle 
threshold (Ct))[141]. A panel of eight prospective reference genes was analyzed (GAPDH, 
ACTB, RPL18, PPIA, YWHAZ, RNF11, H3F3A, SDHA) across all conceptus cDNA samples and 
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a subset of 12 endometrium cDNA samples. Appropriate reference genes were selected using the 
qbase+ geNorm function [141]. Bovine and ovine conceptus target gene expression was 
normalized to two housekeeping genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) 
(geNorm M ≤ 0.5). The endometrial expression for both heifers and ewes was normalized to ring 
finger protein 11 (RNF11) and H3 histone family member 3A (H3F3A) (geNorm M ≤ 0.5) [142]. 
Conceptus and endometrium gene expression was calculated using the following equation: 
Relative quantity (RQ) = 2 (35-Ct). The RQ values were divided by the normalization factor 
(geometric mean of control gene RQ) to obtain the normalized relative quantity (NRQ). The 
NRQ values were then multiplied by a factor of 100. RT-qPCR amplicon size was validated 
using gel electrophoresis (0.8% agarose gel, 1X Tris/Borate/EDTA Buffer, and 0.5 µg/mL 
ethidium bromide) and a 50 bp DNA ladder (New England BioLabs, Ipswich, MA). Gels were 
visualized under ultra-violet (UV) light using the DigiDoc-It Imaging System (Analytik Jena, 
Jena, Germany). Amplicons from RT-qPCR on cDNA from conceptuses were visualized using 
gel electrophoresis to ensure primer specificity (Figure 2.3). 
 
Immunohistochemistry  
 An elongating d15 bovine conceptus was obtained during a previous study [143]. After 
flushing the conceptus from the reproductive tract, the conceptus was placed in 4% buffered 
formalin phosphate (Thermo-Fisher) overnight and embedded in 2% agarose before processing. 
Conceptuses were then embedded in paraffin and sections (4 m) were mounted on microscope 
slides which were deparaffinized using xylene, and were rehydrated through a series of EtOH 
washes, and boiled for 6 min in 0.01M sodium citrate buffer as an epitope retrieval technique. 
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Slides were allowed to cool for 45 min on ice and then were washed twice for 5 min in 1 X PBS. 
The tissue on slides was then enclosed using a wax pen and sections were incubated in 0.3% 
hydrogen peroxide in methanol for 30 min to block endogenous peroxidase activity. Slides were 
washed in 1 X PBS for 5 min and then blocking serum provided with the Rabbit IgG Vectastain 
Elite ABC-Peroxidase Kit (Cat. Number: PK-6101, Vector Laboratories, Inc., Burlington, CA) 
was added to each slide for 20 min to block non-specific binding. Slides were rinsed with 1 X 
PBS and then the Streptavidin/Biotin Blocking Kit (Vector Laboratories, Inc.) was used to block 
endogenous streptavidin and biotin. Following a rinse with 1 X PBS, slides were incubated with 
StartingBlock (PBS) Blocking buffer (Thermo Fisher) for 30 min. A primary rabbit anti-bovine 
polyclonal antibody (SAB2101338, Sigma Aldrich, St. Louis, MO) directed towards the N 
terminal region of LGALS3, was diluted in 1 X PBS (1:500) and 500 L of the solution was 
added to a serial section of the conceptus. Rabbit IgG, at the same concentration as the primary 
antibody, was used as an antibody control and 500 L added to IgG control slides at the same 
concentration as the primary antibody. The primary antibody and antibody control were left on 
slides overnight at 4C. The following morning, a biotinylated secondary antibody, included in 
the Vectastain Elite ABC-Peroxidase Kit, was added to slides according to the manufacturer's 
recommendations. Following a 30 min incubation with the secondary antibody solution, slides 
were rinsed with 1 X PBS for 15 min. Slides were then covered with Vectastain Elite ABC 
reagent for 30 min and once again, rinsed with 1 X PBS for 15 min. ImmPACT DAB peroxidase 
substrate (SK-4105, Vector Laboratories) was added to tissue sections and allowed to incubate 
for 2-5 min. Sections were rinsed in running tap water for 5 min followed by 9 seconds in 
hematoxylin (GH5216, Sigma Aldrich). Sections were immediately rinsed with double distilled 
water for 2 min. Slides were then dipped in Scott’s tap water and placed in double distilled 
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water. Slides were dehydrated in graded alcohol followed by xylene. Coverslips were mounted 
over tissues using Permount (Thermo Fisher) and images were taken using a Zeiss Axio Lab.A1 
microscope (Zeiss, Oberkochen, Germany).  
 
Statistical Analysis  
Relative expression data were analyzed using the general linear model procedure (PROC 
GLM) in the statistical analysis software (SAS Institute Inc.; Cary, NC). For the conceptuses, the 
analyses tested for differences in relative galectin family members. For the endometrium, the 
analysis tested for an effect of pregnancy status on gene expression of select galectin family 
members. All data were log base 10 transformed. Conceptus data are presented as the non-
transformed means ± standard deviation of the mean (SD). Alpha was set at 0.05 and a Tukey’s 
test was included in the analysis of conceptus gene expression. Endometrial data are presented as 
non-transformed least squares means (LSM) ± standard error of the mean (SEM). P-values 
represent the transformed data and P ≤ 0.05 was considered significant.  
 
RESULTS 
 
 According to GenBank, LGALS1, 2, 3, 4, 7, 8, 9, 12, and 13like are present in the bovine 
genome while genes for LGALS1, 2, 3, 4, 7, 8, 9, 12, 14, and 15 are listed as being present in the 
ovine genome in GenBank. Therefore, we investigated the expression of galectins in elongating 
bovine and ovine conceptuses and pregnant and cyclic intercaruncular endometrium. 
Representative images of elongating bovine and ovine conceptuses obtained are shown in Figure 
2.2.  
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Bovine Day 16 Conceptus and Endometrium Galectin Gene Expression  
 The expression of IFNT was investigated via RT-qPCR in d16 elongating bovine 
conceptuses (1293.24 ± 420.87; mean ± SD) as well as the third-most stable reference gene, 
H3F3A (78.91 ± 17.19; mean ± SD). Expression of galectins in d16 bovine conceptuses, depicted 
in Figure 2.3, were found to include LGALS1 (21.80 ± 2.07; mean ± SD), LGALS3 (24.47 ± 6.41; 
mean ± SD), LGALS4 (0.08 ± 0.01; mean ± SD), LGALS7 (0.02 ± 0.01; mean ± SD), LGALS7B 
(0.01 ± 0.005; mean ± SD), LGALS8 (1.73 ± 0.27; mean ± SD), LGALS9 (0.77 ± 0.77; mean ± 
SD), and LGALS13L (0.29 ± 0.10; mean ± SD).  
 Intercaruncular endometrium of pregnant and cyclic heifers expressed LGALS1 (25.66 ± 
2.15 and 30.10 ± 2.15; cyclic and pregnant, respectively; LSM ± SEM), LGALS3 (2.62 ± 0.52 
and 4.40 ± 0.52; cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.05), LGALS4 (5.47 ± 0.66 
and 4.64 ± 0.66; cyclic and pregnant, respectively; LSM ± SEM),  LGALS7 (5.80 ± 2.35 and 2.62 
± 2.35; cyclic and pregnant, respectively; LSM ± SEM; P  ≤ 0.05),  LGALS7B (5.04 ± 2.59 and 
10.04 ± 2.59; cyclic and pregnant, respectively; LSM ± SEM),  LGALS8 (21.01 ± 3.95 and 25.24 
± 3.95; cyclic and pregnant, respectively; LSM ± SEM),  LGALS9 (9.26 ± 2.25 and 24.56 ± 2.25; 
cyclic and pregnant, respectively; LSM ± SEM; P  ≤ 0.001),  and LGALS13L (0.24 ± 0.07 and 
0.14 ± 0.07; cyclic and pregnant, respectively; LSM ± SEM) (Figure 2.4). Expression of 
LGALS1, LGALS8, and LGALS9 were greatest. Compared to cyclic heifers, endometrial 
expression of LGALS7 was less (5.80 ± 2.35 and 2.62 ± 2.35; cyclic and pregnant, respectively; 
LSM ± SEM; P ≤ 0.05), while expression of LGALS9 (9.26 ± 2.25 and 24.56 ± 2.25; cyclic and 
pregnant, respectively; LSM ± SEM; P ≤ 0.001) and LGALS3 were greater (2.62 ± 0.52 and 4.40 
± 0.52; cyclic and pregnant, respectively; LSM ± SEM; P ≤ 0.05) during pregnancy. 
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Ovine Day 14 Conceptus and Endometrium Galectin Gene Expression  
 We were unable to detect gene expression of LGALS2 and LGALS12 in the ovine 
elongating conceptuses nor the endometrium of pregnant and cyclic ewes which could be due to 
primer sets that were not efficient or the tissue did not express these genes. The expression of 
IFNT was investigated via RT-qPCR in d14 elongating ovine conceptuses (Figure 2.5; 3296.74 ± 
1090.66; mean ± SD) as well as the third-most stable reference gene, H3F3A (35.71 ± 1.43; 
mean ± SD). Expression of galectins in d14 ovine conceptuses, depicted in Figure 2.5, was found 
to include LGALS1 (1.90 ± 0.25; mean ± SD), LGALS3 (4.30 ± 0.78; mean ± SD), LGALS4 (0.19 
± 0.10; mean ± SD), LGALS7 (0.04 ± 0.02; mean ± SD), LGALS8 (1.68 ± 0.25; mean ± SD), and 
LGALS13L (1.33 ± 1.09; mean ± SD).  
 Intercaruncular endometrium of pregnant and cyclic ewes expressed LGALS1 (0.83 ± 
0.21 and 0.50 ± 0.21; cyclic and pregnant, respectively; LSM ± SEM), LGALS3 (7.60 ± 1.94 and 
12.36 ± 1.94; cyclic and pregnant, respectively; LSM ± SEM), LGALS4 (3.10 ± 0.38 and 1.78 ± 
0.38; cyclic and pregnant, respectively; LSM ± SEM; P = 0.06),  LGALS7 (0.81 ± 0.24 and 2.25 
± 0.24; cyclic and pregnant, respectively; LSM ± SEM; P  ≤ 0.05), LGALS8 (72.84 ± 17.45 and 
96.60 ± 17.45; cyclic and pregnant, respectively; LSM ± SEM),  and LGALS15 (104.30 ± 234.20 
and 591.35 ± 234.20; cyclic and pregnant, respectively; LSM ± SEM; P = 0.07) (Figure 2.6). 
Expression of LGALS3, LGALS8, and LGALS15 were greatest. Compared to cyclic ewes, 
expression of LGALS7 was greater in pregnant ewes (0.81 ± 0.24 and 2.25 ± 0.24; cyclic and 
pregnant, respectively; LSM ± SEM; P ≤ 0.05) while LGALS4 (3.10 ± 0.38 and 1.78 ± 0.38; 
cyclic and pregnant, respectively; LSM ± SEM; P = 0.06) tended to be less during pregnancy and 
LGALS15 tended to be greater during pregnancy (104.30 ± 234.20 and 591.35 ± 234.20; LSM ± 
SEM; P = 0.07; cyclic and pregnant, respectively). 
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Localization of LGALS3 Protein in an Elongating Bovine Conceptus 
 The presence and localization of LGALS3 protein was investigated in a d15 elongating 
bovine conceptus. Figure 2.8 exhibits staining of LGALS3 protein in the bovine conceptus but 
not in the isotype control slide, rabbit IgG. Staining appeared to be within both the 
trophectoderm and endoderm cytoplasm.  
 
DISCUSSION 
 
Galectins have been suggested to play roles in the regulation of tumors and placental 
angiogenesis, and an immunological role through the regulation of inflammation, adaptive and 
innate immune responses, and immune tolerance  [134-137]. Successful implantation or 
attachment requires tight regulation of endometrial receptivity preparations including cellular 
proliferation preceded by differentiation [119]. The expression profile of cell surface molecules 
alters as uterine receptivity develops. Galectins have been found to increase cell-adhesion by 
associating surface glycoproteins on opposing cells in addition to strengthening other 
intercellular adhesion molecules [120]. Galectins have been highly researched in human and 
mice reproductive biology. The role of many galectins during bovine and ovine pregnancy is 
currently undetermined. In this study, we aimed to better characterize galectin genes expressed 
by the early bovine and ovine conceptus during the elongation phase of development as well as 
to characterize their expression in the endometrium during pregnancy.  
We were unable to detect gene expression of LGALS2 and LGALS12 in the bovine 
elongating conceptuses nor the endometrium of pregnant and cyclic animals which could be due 
to primer sets that were not efficient or the tissue did not express these genes. Early bovine 
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conceptuses have been previously reported to express LGALS1 [144]. Data from the current 
study suggest that both the bovine and ovine elongating conceptuses express LGALS1. Bovine 
endometrial expression of LGALS1 was greater than any other galectin investigated; however, 
expression was not affected by pregnancy status which supports previously published data by 
Okumu et al. (2013) [138]. Tirado-González et al. (2013) reported systemic levels of LGALS1 
were elevated during the first trimester of normal human pregnancy compared to women who 
subsequently suffered a miscarriage, and they suggested that circulating LGALS1 could serve as 
an indicator of early successful pregnancy in humans. Their results supported that LGALS1 is 
playing an immunoregulatory role during pregnancy through the modulation of human leukocyte 
antigen G expressed on trophoblast cells [145]. Expression of LGALS1 also has been associated 
with migration of trophoblast stem cells as the knockout of LGALS1 in trophoblast stem cells 
resulted in the down-regulation of matrix metalloproteinases (MMPs), which are associated with 
successful cytotrophoblast invasion. Overexpression of LGALS1 resulted in the up-regulation of 
MMPs.  Pre-eclampsia patients have a higher placental expression of LGALS1 than normal 
patients suggesting that expression of LGALS1 is a fetal response to elevated maternal systemic 
inflammation. Therefore, LGALS1 was suggested to play a role in human maternal-fetal immune 
tolerance [147]. 
Investigators have addressed the possible roles of LGALS3 at the maternal-fetal interface 
[115, 116]. Bovine and ovine embryos both expressed LGALS3 at d16 and d14, respectively. 
Okumu et al. (2011) published that endometrial LGALS3 expression was not different in 
pregnant and cyclic heifers [138]. Data from the current study suggest expression of LGALS3 is 
higher in the endometrium of pregnant heifers. Previous work suggests LGALS3 expression is 
regulated by different mechanisms in placental tissues compared to in the uterus. After 
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conducting immunohistochemistry (IHC) studies on pregnant murine uteroplacental tissue 
samples, it was concluded that LGALS3 is synthesized by all cell types within the murine 
uteroplacental samples. Levels of LGALS3 mRNA remained constant in murine uterine tissues 
until d12 of gestation and declined thereafter until parturition. Interestingly, in placental tissues, 
LGALS3 mRNA levels remained constant after d12 of gestation until term [115]. In bovine 
tissues, LGALS3 protein has been identified in the cervix, oviduct, uterus, atretic follicles, and 
CL [117]. Specifically, in the nonpregnant bovine uterus, LGALS3 has been localized via IHC in 
epithelial cells as well as macrophages located in the submucosa but absent in endometrial 
glands [117]. In the bovine CL, LGALS3 expression was elevated at the regressed state in 
comparison to all other luteal stages and was localized on steroidogenic cells in the CL [118].  
In addition to LGALS1 and LGALS3, d16 bovine conceptuses expressed LGALS8, 
LGALS9, and LGALS13 while expression of LGALS4, LGALS7, and LGALS7B was minimal. 
Expression of LGALS4 and LGALS7B was detected in the bovine endometrium; however, neither 
was affected by pregnancy status. Pregnancy increased endometrial expression of LGALS9. The 
endometrium of cyclic heifers expressed greater LGALS7 in comparison to pregnant animals. 
First-trimester human placentas express LGALS7 and LGALS7 might play a role in adhesion 
during early pregnancy [148]. In addition, LGALS7 was elevated from weeks 10-12 and 17-20 in 
the serum of women who developed pre-eclampsia later on in pregnancy [149].  
Interestingly, LGALS8 expression in the bovine endometrium was similar to that of 
LGALS1 and LGALS9. In addition, expression of LGALS8 was detected in ovine conceptuses and 
endometrial samples. Though the functions of LGALS8 during early pregnancy have not been 
fully elucidated, LGALS8 was expressed in similar patterns to LGALS1 and LGALS3 in the 
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human trophoblast during the first trimester [150]. In humans, uterodomes form on the plasma 
membrane during the window of implantation (mid-secretory phase) to allow for the blastocyst 
to implant, and LGALS9 was highly expressed by uterodomes during this timeframe, suggesting 
LGALS9 could serve as an endometrial marker of receptivity [151].   
Specifically expressed in sheep, endometrial LGALS15 has been hypothesized to be a 
regulator of blastocyst and trophoblast development. In addition to endometrial LGALS15 in 
sheep, the d14 ovine conceptus expressed LGALS15. Past research reports that the treatment of 
ovine trophectoderm cells with LGALS15 resulted in increased proliferation and migration. 
Through integrin binding, LGALS15 aids in the attachment and migration of the trophectoderm 
[64].  
CONCLUSIONS 
Collectively, findings from this study confirm that various galectins are present in the 
elongating ruminant embryo and are differentially expressed by the endometrium during early 
pregnancy. Previous research on human and mice tissue has noted that the dysregulation of 
galectins leads to abnormal pregnancies and infertility [152]. As little research has focused on 
galectins in ruminant reproduction, future research should focus on characterizing the functions 
of specific galectins during early pregnancy in ruminants.  
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Table 2.1. GenBank accession number, gene name, primer direction, primer sequence, product size and percent amplification
 efficiency of cDNAs amplified during real time quantitative-polymerase chain reaction (RT-qPCR). 
 
 
*To amplify ovine LGALS8, a separate forward primer was used with the following sequence (3’-5’): TCGTGATCATGGTGCTG
Bovine 
GenBank 
Acc. Number 
Ovine 
GenBank 
Acc. Number 
Gene Primer Primer Sequence (5’-3’) 
Product 
Size 
(bp) 
Bovine 
Amp. 
Efficiency 
Ovine 
Amp. 
Efficiency 
Source  
NM_175782.1 NM_001009287.1 LGALS1 Forward GTGGCCGCAGACGCCAAGAG 99 90% 90% [143] 
   Reverse ACGTCCCCATGCGCGTTGAAA     
NM_001102341.2 XM_004010664.4 LGALS3 Forward CAGTGCAGAGGCGTCGGGAAA 121 97% 99% This Study 
   Reverse CTGCCCCAGCAGGCTGGTTT     
NM_001034768.2 XM_027978255.1 LGALS4 Forward TCATGGTCATGACGGAGCACTTCA 127 106% 107% This Study 
   Reverse ATTGAAGCATCAGGTCGCCATCCA     
XM_002694975.5 XM_004015233.4 LGALS7 Forward CTTTAACGTCCCCCACAAGA 136 102% 104% This Study 
   Reverse ATCACTGCCTGGTTCCTCAC     
XM_002694977.4 --- LGALS7B Forward GAGCTTTAATGTCCCCCACA 139 101% --- This Study 
   Reverse ATCACTGCCTGGTTCCTCAC     
NM_001045954.2 XM_027962309.1 LGALS8* Forward TCGTGATCATGGTCCTGAAA 141 96% 98% This Study 
   Reverse TGAAGCCCACAGAGTGAATG     
NM_001015570.3 XM_004012486.3 LGALS9 Forward TCAGCTTCCAGCCTCCAGGG 86 96% 93% [153] 
   Reverse TCCAGGGGCGCTGTGTATGGT     
--- NM_001009238.1 LGALS15 Forward GGTGGATTTCGGCACTGGTA 98 --- 93% This Study 
   Reverse TCCCGTCCGTGAAAGTGTTC     
XM_024979086.1 --- LGALS13L Forward GGTGGATTTCTGCACGGGTA 81 97% --- This Study 
   Reverse ATCACCACCATGCTGTTCGT     
NM_001168279.1 NM_001123400.1 IFNT Forward TGCAGGACAGAAAAGACTTTGGT 69 91% 91% [154] 
   Reverse CCTGATCCTTCTGGAGCTGG     
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Figure 2.1. Images of a d16 bovine (A) and d14 ovine (B) conceptus. 
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Figure 2.2. Galectin RT-qPCR products visualized on a 0.8% agarose gel and a 50 bp DNA 
ladder. Amplicons for cattle (C) and sheep (S) galectins side by side.  
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Figure 2.3. Quantitative real-time PCR analysis of galectins in d16 bovine conceptuses. Data presented are the means ± SD.
 Expression of the genes was normalized to the two control genes, GAPDH and YWHAZ. Relative expression of IFNT and the
 control gene, H3F3A, are also presented. (a-h) Means with the same letter are not statistically different (α = 0.05).  
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Figure 2.4. Quantitative real-time PCR analysis of galectins in pregnant (n=4) and cyclic (n=4) d16 bovine intercaruncular
 endometrium. Galectin expression was normalized to two control genes, H3F3A and RNF11. Data are presented as LSM ±
 SEM.  
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Figure 2.5. Quantitative real-time PCR analysis of galectins in d14 ovine conceptuses. Data presented are the means ± standard
 deviation. Expression of the genes was normalized to the two control genes, GAPDH and YWHAZ. Relative expression of
 IFNT and the control gene, H3F3A, are also presented. (a-g) Means with the same letter are not significantly different (α =
 0.05). 
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Figure 2.6. Quantitative real-time PCR analysis of galectins in pregnant (n=3) and cyclic (n=3) d14 ovine intercaruncular
 endometrium. Galectin expression is relative to two control genes, H3F3A and RNF11. Data are presented as LSM ± SEM.  
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Figure 2.7. (B and D) Galectin-3 (LGALS3) protein in an elongating d15 bovine conceptus. (A 
and C) Absence of DAB staining in IgG isotype control serial section of the conceptus. 
Images were taken on a Zeiss Axio Lab.A1 microscope at 10 X (A-B) and 20 X (C-D) 
magnification.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C D 
B A 
IgG control                    Anti-LGALS3 
 
  
 
44 
CHAPTER THREE 
 
EFFECT OF INTERFERON TAU AND GALECTIN-3 ON BOVINE ENDOMETRIAL 
EPITHELIAL AND FIBROBLAST CELL TRANSCRIPTOMES IN 3D CELL CULTURE 
 
 
ABSTRACT 
 
Interferon-tau (IFNT), secreted by the elongating bovine conceptus, is the maternal 
recognition of pregnancy signal that suppresses the endometrial luteolytic mechanism by 
modifying expression of genes in specific cell types within the endometrium. The conceptus also 
secretes galectin proteins, specifically galectin-3. This study assessed the effect of IFNT 
(Experiment 1) and LGALS3 (Experiment 2) on bovine endometrial epithelial and fibroblast cell 
transcriptomes when the mid-luteal phase endometrial cells were cultured in a 3D environment. 
In Experiment one, epithelial cells, cultured in Transwell inserts above the fibroblast cells, were 
treated with RPMI media alone (control; n=4) or treatment media (RPMI with 5% FBS and 1% 
ABAM) containing 100 ng of recombinant ovine IFNT (n=3) for 6 h. In Experiment two, cells 
were treated with either RPMI media alone (Control; n=5), pregnant ovine uterine flush fluid, 
theoretically containing INFT, diluted with treatment media 1:1 (n=4), or treatment media 
(RPMI with 5% FBS and 1% ABAM) containing either 100 or 1000 ng of recombinant mouse 
LGALS3 (n=5) for 6 h. Total RNA was extracted from both cell types and the transcriptomes 
were assayed by RNA Sequencing and RT-qPCR. Interferon-tau regulated 673 and 83 genes 
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(differentially expressed genes or DEGs) in epithelial and fibroblast cells, respectively (P ≤ 
0.001; FDR P ≤ 0.05). Many of the DEGs identified in the epithelial (205) and fibroblast cells 
(64) were previously reported as IFNT and bovine conceptus-induced DEGs in intact bovine 
endometrium, including well-known ISGs such as ISG15, MX1, MX2, OAS1, and OAS2. 
Surprisingly, the ZC3HAV1 gene, which was recently found to be up-regulated in intact bovine 
endometrium in response to the conceptus, was only up-regulated in fibroblast cells despite 
applying IFNT to the apical surface of the epithelial cells in 3D culture. The RNA-Seq analysis 
of the bovine endometrial cells treated with mouse LGALS3 protein resulted in the identification 
of a single gene, RPL23A, that was upregulated in epithelial cells treated with 100 ng of 
LGALS3 (P ≤ 0.001; FDR P ≤ 0.05). This study supports the idea that the 3D culture of bovine 
endometrial cells may be utilized to study early conceptus-maternal crosstalk and identify 
endometrial cell type-specific responses to the conceptus. 
 
INTRODUCTION 
 
The beef cow/calf industry experiences an annual loss exceeding $1.2 billion, with the 
largest contributing factor being embryonic loss [1]. The highest incidence of pregnancy loss in 
cattle occurs during the embryonic period of gestation, with 40% occurring between d8 and d17 
[2-4]. Bovine embryos will elongate from approximately 2 mm on d13 into an approximately 6 
cm filamentous structure, spanning the length of the uterine horn by d19 [19, 20, 30]. During this 
time, the conceptus secretes a substance to communicate to the maternal endometrium its 
presence and prolong progesterone (P4) production by the CL [5]. This secretory protein, IFNT, 
is derived from the bovine mononuclear trophectoderm. The presence of IFNT stimulates the 
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expression of ISGs in addition to blocking the pulsatile secretion of endometrial PGF from the 
uterine horn and ultimately, luteolysis [42]. Luteolysis, the functional and structural regression of 
the CL, is prevented due to the paracrine release of IFNT from the conceptus which acts to 
modify endometrial PGF through the silencing of uterine epithelial cell estrogen receptor alpha 
(ESR1) and thus, epithelia oxytocin receptor (OTR) [155]. Overall, luteal P4 is maintained and 
supports gestation until the establishment of placental P4.  
 Interferon-tau is a type I interferon. The type I interferons bind IFNAR to signal a 
biological response. There is a single Type II interferon family member, IFNG, which binds the 
IFNGR [40]. The IFNT acts on the endometrium and modifies endometrial cell gene expression. 
The pregnancy recognition signal, IFNT, affects the differential expression of genes in the LE, 
dGE, sGE, and stroma [36, 41]. The genes affected, ISGs, are categorized in two distinct 
classifications, classical and non-classical ISGs, which are spatially stimulated by IFNT within 
the stroma/dGE and LE/sGE, respectively [42, 43]. Type I and II IFNs initiate the expression of 
classical ISGs through stimulation Jak-STAT pathways resulting in phosphorylation of their 
respective receptors activating STAT. Classical ISGs expressed in the stroma/dGE in response to 
IFNT include STAT1 and STAT2, IRF1, ISG15, and 2’-5’-oligoadenylate synthetase 1 (OAS1) 
[45, 156, 157]. Transcriptomic analysis of ruminant endometrium has led to the identification of 
non-classical ISGs which are stimulated by IFNT and are primarily induced by P4 spatially in 
the LE/sGE [20, 41]. Genes include CST3, CTSL, and LGALS15 in sheep [42].  In the LE/sGE, 
interferon regulatory factor-2 (IRF2) prevents the IFNT from regulating gene expression of 
classical ISGs.  
 Mathew et al. (2019) published data identifying conceptus and IFNT induced DEGs 
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[143]. Endometrial explants were cocultured with d15 conceptuses from artificial insemination 
or IVF origin, or 100 ng of IFNT, or media alone. Transcriptome differences were analyzed via 
RNA-Seq and RT-qPCR. Conceptus induced, IFNT-dependant DEGs were identified through the 
grouping of explant DEGs that were differentially expressed in response to all three treatment 
groups as well as DEGs similar between the IFNT and AI conceptus treated explants [143].  
Galectins are a large family of -galactoside-binding animal lectins that have numerous 
physiological functions. Lectins bind carbohydrates and result in cell agglutination while playing 
vital roles in pathogen defense, cell trafficking, and immune regulation [82, 83]. Galectins are 
ancient members of a lectin family which are characterized by having conserved amino acid 
sequences with at least one CRD and the ability to recognize -galactoside structures located on 
cell surface glycoconjugates [85, 86]. Elongating bovine embryos have been found to express 
galectin-1 (LGALS1) and LGALS3. Recently, LGALS3 was identified to play an important part in 
the preparation of the endometrium for implantation with a presence in the endometrium and 
trophoblast cells. Given the resemblances of tumor invasion and the migration of trophoblast 
cells, investigators have addressed the possible roles of LGALS3 at the maternal-fetal interface 
regarding implantation [115, 116]. After conducting IHC studies on pregnant murine 
uteroplacental tissue samples, it was concluded that LGALS3 is synthesized by all cell types 
within the murine uteroplacental samples. Levels of LGALS3 mRNA remained constant in 
murine uterine tissues until d12 of gestation and declined thereafter until parturition. 
Interestingly, in placental tissues, LGALS3 mRNA levels remained constant after d12 of 
gestation until term [115]. In bovine tissues, LGALS3 protein has been identified in the cervix, 
oviduct, uterus, atretic follicles, and CL [117]. Specifically, in the nonpregnant bovine uterus, 
LGALS3 has been localized via IHC in epithelial cells as well as macrophages located in the 
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submucosa but were absent in endometrial glands [117].  
In the past, 2D monoculture techniques have been utilized to investigate cellular 
processes of bovine epithelial and fibroblast cells [129, 130]. The 3D transwell culture system 
published by MacKintosh et al. (2013) enables the coculture of two cells types, which would 
normally interact in vivo [127]. MacKintosh et al. utilized bovine endometrial epithelial and 
fibroblast cells in this system to investigate the effects of lipopolysaccharide (LPS) in a post-
partum uterine disease [127]. To better simulate the columnar arrangement of epithelial cells in 
vivo, a 3D culture allows epithelial cells to maintain a physiological polarity in vitro due to tight 
junctions unlike traditional 2D cell culture techniques [127, 128]. Tight junctions are imperative 
to epithelial cellular functions because the passage of ions and molecules paracellularly is 
regulated by tight junctions. A measurement that reflects epithelial integrity, TEER, can be 
measured via an epithelial volt-ohm meter [127].  
This aim of this study was to examine the effect of IFNT and LGALS3 on bovine 
endometrial epithelial and fibroblast cell transcriptomes when cells are cultured in a 3D 
environment. 
MATERIALS AND METHODS 
Primary Cell Isolation, Culture, and Treatment 
 Bovine reproductive tracts utilized to isolate endometrial cells were collected from a local 
abattoir. The tracts were chosen based on the appearance of a mid-luteal phase CL and the 
absence of either pregnancy and/or infection [158]. Cells were isolated from different animals for 
the IFNT Experiment (Experiment 1; n=3-4) and LGALS3 Experiment (Experiment 2; n=4-5). 
The reproductive tracts were immediately placed on ice and transported to the laboratory. Upon 
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arrival at the laboratory, reproductive tracts were rinsed with water, and the broad ligament and 
the cervix were removed. The remaining reproductive tract was sprayed with 70% ethyl alcohol 
(EtOH), and the uterine horn ipsilateral to the CL was removed with a scalpel. The tract was then 
placed in a cold dissecting tray lined with 70% EtOH soaked paper towels and sprayed once 
again with 70% EtOH. A cut was made along the anti-mesometrial side of the uterine horn 
ipsilateral to the CL.  
Bovine endometrial epithelial and fibroblast cells were isolated from uterine horn 
ipsilateral to the CL [127]. Briefly, the exposed endometrium was rinsed with 1X phosphate 
buffered saline (PBS) (Gibco, Gaithersburg, MD) containing 1% antibiotic-antimycotic (ABAM) 
(Gibco). Thin intercaruncular endometrial strips were dissected and placed in 25 mL of hank’s 
balanced salt solution (HBSS) (Gibco). Endometrial strips were washed twice in 25 mL of HBSS 
and trimmed into 3-5 mm pieces and washed in a final HBSS wash (25 mL) containing 1% 
ABAM. Endometrial strips were then incubated for 10 min at 38.8°C in atmospheric oxygen and 
5% CO2. The wash was then drained from the conical tube and 40 mL of filter-sterilized enzyme 
solution [49.5 mL HBSS, 25 mg Collagenase II (Sigma-Aldrich), 50 mg bovine serum albumin 
(BSA) (Sima-Aldrich), 700 µL Trypsin-EDTA-HBSS solution (Sigma-Aldrich; Gibco), and 125 
µL DNase I (Sigma-Aldrich)] was added. The endometrium in enzyme solution was placed in a 
water bath at 38.8°C for 1 h with manual agitation every 10 min.  
Following incubation, the endometrium in enzyme solution was filtered through a 100 
M filter placed over a 40 M filter (Corning Inc.; Tewksbury, MA). The filtered solution was 
placed with 5 mL of prewarmed (38.8°C) HBSS with 10% fetal bovine serum (FBS) (VWR 
International, Radnor, PA). The 40 M filter, containing sheets of epithelial cells, was then 
overturned and washed with 30 mL of pre-warmed (38.8°C) Roswell Park Memorial Institute 
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1640 (RMPI) (Gibco), 5% FBS (VWR International), and 1% ABAM (Gibco) (complete media). 
Fifteen mL aliquots of the cell suspension were transferred into T75 flasks (Greiner Bio-One, 
Monroe, NC) and cells were allowed to attach for 48 h at 38.8°C in atmospheric oxygen and 5% 
CO2. Fibroblasts, in filtered solution, were centrifuged at 700 x g for 7 min at 25°C. The 
supernatant was aspirated and 5 mL of prewarmed (38.8°C) sterile water was added to the pellet 
and lightly vortexed for 30 s. After, 45 mL of HBSS (Gibco) containing 10% FBS (VWR 
International) was added to the cells which were then filtered once again through a 40 M filter. 
Flow through was centrifuged at 700 x g for 7 min at 25°C. The supernatant was aspirated and 
45 mL of complete media was added to re-suspend pellet. Fifteen mL aliquots were added to T75 
flasks which were placed in the incubator at 38.8°C in atmospheric oxygen and 5% CO2. After 
18 h, fibroblasts in flasks were washed with 10 mL of prewarmed 1X PBS (Gibco) and 15 mL of 
complete media was added. Every 2d, both fibroblast, and epithelial flasks were rinsed with 1X 
PBS (Gibco) and 15 mL of fresh complete media was added until the cells reached confluency. 
Once approximately 80% confluent, cells were dislodged from the flask with 1.5-2 mL of 
Accutase (Sigma-Aldrich) and passed into new T75 flasks in complete media.  
Cells were counted using a hemocytometer and once the epithelial cell concentration of 
3x105 cells/mL was reached, cells were removed using 2-3 mL of Accutase (Sigma-Aldrich) and 
placed in polyethylene terephthalate transwell cell culture inserts with a pore size of 0.4 µm 
(Millipore Sigma, Burlington, MA). Before the addition of epithelial cells, transwell inserts were 
coated with 25-30 µL of Matrigel (Corning Inc.) with ice-cold RPMI (Gibco) at a 1:8 dilution. 
Transwell inserts were placed in a 24-well plate containing 800 L of complete media. Cells 
were cultured in transwell inserts for 9d. On d9 (day of treatment), TEER was calculated using 
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the following formula: TEER (Ωcm2) = (sample resistance – blank resistance) X membrane area. 
Resistance values were obtained by using a Millicell ERS-Voltohmmeter (Millipore Sigma).  
The 3D cultures were conducted as previously described [127]. The day prior to treatment, 1 mL 
of fibroblast cells at the concentration of 1 X 105 cells/mL were plated per well in new 24 plates. 
Fibroblasts were allowed to adhere and 18 h later, the cells were washed with 1 X PBS (Gibco) 
and new media was added [treatment media; RPMI (Gibco), 5% FBS (VWR International), and 
1% ABAM (Gibco)]. The transwell inserts containing epithelial cells were then added to the 
fibroblast cells and new treatment media was added to the transwell inserts.  
 
Experiment One 
After 2 h, new treatment media alone (Control) or treatment media containing 100 ng of 
recombinant ovine IFNT (oIFNT), kindly donated by Dr. Gilles Charpigny of INRA, Biologie du 
Développement et Reproduction (Jouy en Josas, France), was added to well inserts containing 
epithelial cells for 6 h [143]. Fibroblast cell media was not changed. The experiment was 
repeated at least 4 times (cells from 4 different uteri). However, the oIFNT treatment for one 
uterus was lost, therefore, n=3-4.  Both treatments were applied to three 3D cell cultures from 
each uterus.  
 
Experiment Two 
After 2 h, 300 µL of new treatment media alone (Control), d14 pregnant ovine flush fluid 
(FF) (diluted 1:1 with treatment media), or treatment media containing either 100 or 1000 ng of 
recombinant mouse LGALS3 protein (Catalog Number: 9039-GA; R&D Systems, Minneapolis, 
MN) was added to well inserts containing epithelial cells for 6 h. The ovine pregnant uterine 
  
 
52 
flush fluid, theoretically containing IFNT, was obtained during a previous study by flushing the 
uterine horn ipsilateral to the CL of a d14 pregnant ewe with 20 mL of 1 X PBS (Thermo 
Fisher). The presence of a conceptus confirmed pregnancy. Fibroblast media was not changed. 
The experiment was replicated with cells from five different uteri. The FF treatment from one 
replication was lost, therefore, n=4-5 uteri. All treatments were applied to three 3D cell cultures 
from each uterus. 
 
RNA Isolation and RNA Sequencing (RNA-Seq)  
Total RNA was extracted from both cell types, separately, using the Qiagen RNeasy Kit 
(Qiagen) for Experiment one while the E.Z.N.A. Total RNA Kit I (Omega Bio Tek, Inc.) was 
used to collect RNA for Experiment two. Both kits were used according to the manufacturer’s 
recommendations. Briefly, the media was collected and the membrane from transwell inserts was 
removed using a scalpel, placed in lysis buffer, and agitated using a pipette tip. Lysis buffer was 
added to fibroblast cells in wells and gently scraped using a pipette tip to obtain fibroblast RNA. 
The three RNA samples per treatment for both cells types were pooled. The concentration of 
RNA and integrity was determined using NanoDrop (NanoDrop ND-1000, NanoDrop 
Technologies) and Bioanalyzer (2100 Bioanalyzer, Agilent Technologies), respectively. The 
RNA integrity number (RIN) values obtained from the Bioanalyzer ranged from 8.6-10.0. The 
RNA was stored at -80°C until cDNA was synthesized.  
 RNA library preparation and sequencing was performed by the University of Missouri 
DNA Core facility as previously described by Moraes et al. [159]. The raw sequences (fastq) 
underwent adapter removal and quality trimming utilizing Trimmomatic [160]. The quality reads 
were then mapped to the bovine reference genome ARS-UCD1.2 using Hisat2 mapper, a 
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sensitive and fast alignment program of next-generation sequencing data [161]. The sorted 
binary alignment maps and the NCBI gene annotation of the ARS-UCD1.2 assembly were 
subjected to FeatureCounts [162] to quantify read counts of genes for each sample. Differential 
gene expression analysis between sample groups was performed by robustly fitting the 
expression data to a weighted generalized linear model (GLM) using edgeR robust [163]. 
 To perform a Gene Ontology (GO) analysis of statistically significant transcripts 
generated by RNA-Seq data, DAVID Bioinformatics Resource 6.8 was utilized [164]. Pathway 
analyses included were an enriched biological process (BP) in addition to the Kyoto 
Encyclopedia of Genes and Genomes (KEGG). During the annotation, the GO Direct category 
was used which provides mappings directly annotated by the source database and the Homo 
sapien background was used during the analysis. The GO Direct and KEGG categories were 
considered enriched when P ≤ 0.05.  
 
Reverse Transcription and Quantitative real-time PCR (RT-qPCR) 
Following the manufactures recommendations, cDNA was synthesized using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Briefly, 500 ng of RNA and 
nuclease-free water was added to 10 µL of master mix to reach a total volume of 20 µL. No-
reverse transcriptase control samples were also prepared. Following a 2 h cDNA synthesis at 
37˚C, 5 µL of each sample was pooled and the remaining cDNA was diluted 1:20 using 
nuclease-free water. Pooled cDNA was used to generate 7 standards (1:4 serial dilutions). 
Standards were used to calculate primer efficiencies (E) using the following equation: E = [10(-
1/slope)-1]. The slope is a plot of observed Ct values versus the 7 standard serial dilutions. Percent 
efficiency was then obtained by dividing E by 2 and multiplying by 100.  
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Quantitative real-time PCR was utilized to examine gene expression differences in 
response to treatment and to verify the data obtained from RNA-Seq. The CFX96 Real-Time 
PCR machine (Bio-Rad Laboratories) was used to perform RT-qPCR reactions. All primers were 
designed using Primer3Plus (Version 2.4.2) unless otherwise noted. Sample RT-qPCR reactions 
were carried out in 20 L reactions in duplicate [10 L of SYBR Green Master Mix (Catalog 
Number: A25743; Applied Biosystems), 1.2 L of forward and reverse primer mix (1 µM final 
concentration), 2.6 L nuclease-free water, and 5L of cDNA template (6.6 ng RNA 
equivalent)]. The RT-qPCR reaction of no-reverse transcriptase controls and no-template 
controls were included. All samples from an experiment were assayed in a single 96-well plate. 
Thermo-cycling conditions were as follows: 50°C for 2 min, 95°C for 2 min, which was 
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. A disassociation analysis was 
included for each primer set and the presence of a single, sharp peak was confirmed. 
The qbase+ package (Biogazelle) was used to analyze and calculate relative gene 
expression values. Average RT-qPCR Ct values were imported into qbase+ software, which was 
used to analyze real-time data and generate the normalized relative quantity (NRQ) of genes of 
interest using a generalized delta-delta quantification cycle method (ΔΔCq; also known as 
ΔΔCT)[141]. A panel of eight prospective reference genes was analyzed (GAPDH, ACTB, 
RPL18, PPIA, YWHAZ, RNF11, H3F3A, SDHA) across a subset of 12 random cDNA samples 
and two reference genes were selected using the qbase+ geNorm function [141]. Expression was 
normalized to two housekeeping genes, succinate dehydrogenase complex flavoprotein subunit 
A (SDHA) and ring finger protein 11 (RNF11) in the oIFNT Experiment and the two genes, 
peptidylprolyl isomerase A (PPIA) and SDHA, in the LGALS3 Experiment. These reference 
genes were found to be the most stably expressed across the subset of samples for each 
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experiment (geNorm M ≤ 0.5) [142].  Sizes of RT-qPCR amplicons were validated using gel 
electrophoresis (0.8% agarose gel, 1X Tris/Borate/EDTA Buffer, and 0.5 µg/mL ethidium 
bromide) and a 50 bp DNA ladder (New England BioLabs). Gels were visualized under ultra-
violet (UV) light using the DigiDoc-It Imaging System (Analytik Jena).  
 
Statistical Analysis 
Log-transformed sample NRQ data were analyzed using the proc GLM in the statistical 
analysis software (SAS Institute Inc.). The analysis tested the effect of recombinant oIFNT 
(Experiment one) or recombinant mouse LGALS3 (Experiment two) on endometrial cell gene 
expression. The epithelial and fibroblast NRQ data were analyzed separately. Residual data were 
scrutinized for normality using the PLOTS= (diagnostics residuals) statement. If residuals were 
not normally distributed, they were square root (sqrt) transformed. Data are presented as non-
transformed least square means ± standard error of the least squares means (LSM ± SEM). 
Statistical significance was declared at P ≤ 0.05.  
 
RESULTS 
Experiment One 
Differentially Expressed Genes in Response to oIFNT 
 The RNA-Seq analysis identified 673 and 83 DEGs (up- or down-regulated) in the 
epithelial and fibroblast cells, respectively, in response to treatment with 100 ng of oIFNT in the 
3D culture system (P ≤ 0.001; FDR P ≤ 0.05; Figure 3.2). Epithelial cell data consisted of 632 
and 41 DEGs that were up- and down-regulated, respectively. Fibroblast cell data identified 83 
DEGs that were up-regulated and 0 DEGs that were down-regulated. To potentially identify 
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conceptus IFNT responsive genes specifically in epithelial and fibroblast cells, data were 
compared to recently published RNA-Seq data of bovine endometrial explants incubated with an 
elongating, d15 bovine conceptus and explants treated with 100 ng/mL of recombinant oIFNT. 
The DEGs, published by Mathew et al. (2019) were considered to be conceptus induced, IFNT 
dependent DEGs (Figure 3.2) [143]. Comparison of DEGs between epithelial cells and fibroblast 
cells treated with 100 ng/mL of oIFNT in a 3D environment with the conceptus induced, IFNT 
dependent DEGs resulted in the identification of 224 DEGs in common with explants and 
epithelial cells or fibroblast cells in 3D culture (Figure 3.2). Sixty-nine DEGs were in common 
between all three groups (Figure 3.2). Explants shared 154 DEGs with epithelial cells only and a 
single gene was differentially expressed in explants and fibroblast cells only (Figure 3.2). All 
DEGs in common between explants (Mathew et al. 2019) and endometrial cells in 3D culture 
from the current study were up-regulated [143].   
 
 Epithelial-Derived DEGs in Response to oIFNT 
 Analysis of RNA-Seq data resulted in the identification of 632 genes that were up-
regulated and 41 genes that were down-regulated in bovine endometrial epithelial cells in 
response to treatment with 100 ng/mL of oIFNT (P ≤ 0.001; FDR P ≤ 0.05; Figure 3.2). 
Epithelial cells shared 223 up-regulated genes with explant data and 154 of these DEGs were up-
regulated only in the epithelial cells during 3D culture. The top 10 genes with the greatest log 
fold change (logFC) of the 223 DEGs shared between explants and epithelial cells were kinesin 
family member 5C (KIF5C; logFC 8.66), hematopoietic SH2 domain containing (HSH2D; logFC 
7.86), ATPase phospholipid transporting 8B4 (ATP8B4; logFC 7.52), indoleamine 2,3-
dioxygenase (IDO1; logFC 7.18), forkhead box S1 (FOXS1; logFC 7.17), growth hormone 
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secretagogue receptor (GHSR; logFC 5.67), prostate androgen-regulated mucin-like protein 1 
(PARM1; logFC), apolipoprotein L3 (APOL3; logFC 5.34), melanin concentrating hormone 
receptor 1 (MCHR1; logFC 4.88), and guanylate-binding protein 2 (GBP2; logFC 4.52) (Figure 
3.2; Table 3.2).The top 20 DEGs in common out of the 223 DEGs are listed in Table 3.2 with 
their respective epithelial log fold change differences and fibroblast log fold change differences, 
if applicable. Of the 223 DEGs, 69 were also up-regulated in both epithelial and fibroblast cells 
in response to oIFNT (Figure 3.2). 
 Further analysis of DEGs shared between explants and epitheial cells through RT-qPCR 
validated that genes including MX dynamin like GTPase 1 (MX1) (Figure 3.3; 1.92  15.45 and 
59.62  17.83; Control and oIFNT, respectively;  LSM  SEM; P < 0.05), MX2 (Figure 3.4; 0.59 
 37.32 and 680.18  43.1; Control and oIFNT, respectively;  LSM  SEM; P < 0.001), OAS1 
(Figure 3.5; 0.80   10.34 and 39.03   11.94; Control and oIFNT, respectively;  LSM  SEM; P 
< 0.05;), galectin-3 binding protein (LGALS3BP; Figure 3.6; 0.72  0.40 and 2.79  0.50; 
Control and oIFNT, respectively;  LSM  SEM; P < 0.001), galectin-9 (LGALS9; Figure 3.7; 
3.07  2.99 and 36.78  3.45; Control and oIFNT, respectively;  LSM  SEM; P < 0.001), OAS2 
(Figure 3.8; 0.59  1.06 and 9.97  1.22; Control and oIFNT, respectively;  LSM  SEM; P < 
0.01;), BATF2 (Figure 3.9; 0.59  1.03 and 8.51  1.19; Control and oIFNT, respectively;  LSM 
 SEM; P < 0.001), and TNF superfamily member 13b (TNFSF13B; Figure 3.12; 0.48  0.80 
and 12.7  0.93; Control and oIFNT, respectively;  LSM  SEM; P < 0.001) were significantly 
upregulated in the oIFNT treated epithelial cells. Microtubule associated protein 6 (MAP6) was 
found to be significantly down-regulated after oIFNT treatment by RNA-Seq (logFC -6.50; P ≤ 
0.001; FDR P ≤ 0.05) and RT-qPCR validation of this gene exhibited MAP6 expression in 
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response to IFNT was less than in control cells, although not significantly (Figure 3.11; 1.86  
0.30 and 0.35  0.35; Control and oIFNT, respectively; LSM  SEM; P = 0.17).  
 
Fibroblast-Derived DEGs in Response to oIFNT 
 The RNA-Seq data identified 83 up-regulated and 0 down-regulated transcripts in 
fibroblast cells treated with oIFNT in the 3D cell culture (P ≤ 0.001; FDR P ≤ 0.05). Fibroblast 
cells shared 69 DEGs with both explants and epithelial cells, all of which were up-regulated. Of 
the 69 genes, the following were the top 10 greatest up-regulated in fibroblast cells: OAS2 
(logFC 9.63), interferon induced protein 44 like (IFI44L; logFC 8.66), RSAD2 (logFC 8.35), 
ZBP1 (logFC 8.06), MX2 (logFC 7.83), MX1 (logFC 7.77), PLAC8 (logFC 7.75), IFI44 (logFC 
7.63), TNF superfamily member 10 (TNFSF10; logFC 7.50), and sterile alpha motif domain 
containing 9 (SAMD9; logFC 7.46). A single transcript (also recently reported as a conceptus and 
oIFNT induced DEG in endometrial explants), zinc finger CCCH-type antiviral protein 1 
(ZC3HAV1; logFC 0.87) was differentially expressed in fibroblast cells (up-regulated) but not 
epithelial cells (P ≤ 0.05) [143].  
Validation of RNA-Seq data through RT-qPCR confirmed genes including MX1 (Figure 
3.3; 0.01  0.14 and 5.28  0.17 Control and oIFNT, respectively;  LSM  SEM; P < 0.001), 
MX2 (Figure 3.4; 0.01  1.61 and 4.37  1.85 ; Control and oIFNT, respectively;  LSM  SEM; 
P < 0.01), OAS1 (Figure 3.5; 0.04  0.95 and 10.86  1.09; Control and oIFNT, respectively;  
LSM  SEM; P < 0.001), LGALS3BP (Figure 3.6; 0.58  0.07 and 1.18  0.08; Control and 
oIFNT, respectively;  LSM  SEM; P < 0.01), LGALS9 (Figure 3.7; 0.04  0.15 and 0.79  0.18; 
Control and oIFNT, respectively;  LSM  SEM; P < 0.05), OAS2 (Figure 3.8; 0.25  0.13 and 
1.62  0.15; Control and oIFNT, respectively;  LSM  SEM; P < 0.001), BATF2 (Figure 3.9; 
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0.30  0.25 and 1.55  0.29; Control and oIFNT, respectively;  LSM  SEM; P < 0.01), and 
TNFSF13B (Figure 3.12; 0.33  0.35 and 1.48  0.41; Control and oIFNT, respectively;  LSM  
SEM; P < 0.05) were increased in response to oIFNT treatment. Expression of ZC3HAV1 in 
epithelial cells was unaltered by the presence of oIFNT protein in culture, while in fibroblast 
cells, expression of this gene increased due to oIFNT (Figure 3.13; Control and oIFNT, 
respectively; LSM  SEM; P < 0.05). 
 
Gene Ontology Analysis 
The gene ontology analysis of the 223 up-regulated epithelial DEGs in response to 
oIFNT identified 97 enriched biological processes (P ≤ 0.001; Table 3.4). The top 5 enriched 
pathways include the following: 1) type I interferon signaling pathway, 2) defense response to 
virus, 3) interferon-gamma mediated signaling pathway, 4) response to virus, and 5) negative 
regulation of viral genome replication (P ≤ 0.001; Table 3.4). The KEGG pathway analysis 
found 12 enriched pathways (P ≤ 0.05; Table 3.4). The top 5 pathways include 1) influenza A, 2) 
herpes simplex infection, 3) hepatitis C, 4) measles, 5) RIG-1-like receptor signaling pathway (P 
≤ 0.001; Table 3.4).  
The 70 oIFNT-stimulated DEGs in fibroblast cells, which includes the 69 shared with the 
epithelial cells and ZC3HAV1, were identified to be associated with 43 biological processes. The 
top 5 enriched pathways include 1) defense response to virus, 2) type I interferon signaling, 3) 
response to virus, 4) negative regulation of viral genome replication, and 5) interferon-gamma-
mediated signaling pathway (P < 0.001; Table 3.5). The KEGG pathway analysis found 7 
enriched pathways (P ≤ 0.05; Table 3.5). The top 5 pathways include 1) influenza A, 2) herpes 
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simplex infection, 3) measles, 4) RIG-I-like receptor signaling, and 5) hepatitis C (P ≤ 0.001; 
Table 3.5).  
 
Experiment Two 
The Effect of Mouse-LGALS3 on Bovine Endometrial Epithelial and Fibroblast Cells in 3D 
Culture 
 The effect of a recombinant mouse LGALS3 protein on bovine endometrial epithelial and 
fibroblast cells in 3D culture was analyzed by RNA-Seq. Results indicated a single gene, 60S 
ribosomal protein L23A (RPL23A), was up-regulated in epithelial cells (log FC 4.05). The 
transcriptome of fibroblast cells was not affected by LGALS3 treatment. The gene, RPL23A, was 
analyzed through RT-qPCR, however, an increase in expression of this gene was unable to be 
validated using this method (Table 3.6). The cells that received the lower concentration of 
LGALS3 protein (100 ng) and the control-treated cells were analyzed through RNA-Seq. The 
relative expression of other genes including C-X-C motif chemokine receptor 4 (CXCR4), 
doublesex- and mab-3-related transcription factor A1 (DMRTA1), ISG15, LGALS3BP, leukemia 
inhibitory factor (LIF), proline-rich transmembrane protein 3 (PRRT3), and scavenger receptor 
cysteine-rich family member with 4 domains (SSC4D) was assessed through RT-qPCR to see 
whether a higher concentration of LGALS3 (1000 ng) affected their expression. Of the genes 
analyzed, neither concentration of LGALS3 affected their relative expression (Table 3.6). 
 
 
 
  
 
61 
The Effect of Day 14 Pregnant Ovine Flush Fluid on Endometrial Epithelial and Fibroblast Cell 
Transcriptomes Cultured in 3D 
The ovine flush fluid treatment up-regulated expression of CXCR4 (5.12 ± 0.98 and 9.50 
± 1.10; Control and FF, respectively;  LSM  SEM; P < 0.01), ISG15 (0.50 ± 5.31 and 130.27 ± 
5.94; Control and FF, respectively;  LSM  SEM; P < 0.001), LGALS3BP (0.98 ± 0.16 and 4.12 
± 0.18; Control and FF, respectively;  LSM  SEM; P < 0.001), and LIF (4.27 ± 0.77 and 7.11 ± 
0.86; Control and FF, respectively;  LSM  SEM; P < 0.05) as indicated by RT-qPCR (Table 
3.6).  
 
DISCUSSION 
 
 The aim of this study was to identify IFNT and LGALS3 induced DEGs in the bovine 
endometrial epithelium and fibroblast cells in a 3D cell culture system. To date, several studies 
have addressed endometrial genes stimulated by the elongating ruminant conceptus particularly 
in sheep, however, literature is lacking information examining differential expression within 
endometrial epithelial and/or stromal cells, specifically, during early bovine pregnancy [143, 
165, 166].  
 Endometrial cells of the uterus regulate maternal-conceptus communication through the 
differential expression of genes. The endometrium also contains other cells including glands, 
endothelial cells, and immune cells. Past research has noted that endometrial epithelial and 
fibroblast cells, which largely comprise the endometrium, have different expression profiles [38, 
167-169]. During this preimplantation and conceptus elongation in ruminants, genes 
differentially expressed in fibroblasts have been documented to be associated with maternal 
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immunosuppression to protect the semi-allogenic conceptus [42, 165].  The JAK-STAT 
signaling pathway is activated via IFNT to stimulate classical ISGs during the elongation phase 
in the ruminant endometrium [170]. Epithelial and fibroblast cells treated with IFNT in the 3D 
cell culture had 69 differentially expressed transcripts in common with bovine endometrial 
explants treated with IFNT or an elongating Day 15 conceptus. There were 154 DEGs shared 
specifically between the epithelial cells and explants that were not shared with the fibroblasts. 
On the other hand, there was one DEG shared between the fibroblast cells and explants but not 
with the epithelial cells [143].   
 
3D Cell Culture 
Epithelial and fibroblast cell-specific responses to IFNT have not been elucidated, 
particularly in a 3D cell culture system. Recently, 3D cell culture models have been utilized to 
investigate cellular communication mechanisms and responses. Mackintosh et al. (2013) found 
the coculture of bovine endometrial epithelial and stromal cells enabled the polarization of 
epithelial cells. The 3D cultures were treated with oxytocin and arachidonic acid to assay the 
physiological function of the model. The cells were also treated with lipopolysaccharide (LPS) to 
mimic a bacterial infection.  In the present study, we assessed the use of a 3D culture system to 
study maternal-conceptus crosstalk. 
The IFNT was administered apically to the 3D culture. The RNA-Seq data identified 673 
DEGs in epithelial cells and 83 DEGs in fibroblast cells (P ≤ 0.001; FDR P ≤ 0.05), therefore, 
apical treatment to the 3D system elicited a response in both cell types. We do not know if the 
IFNT traveled through the epithelium layer to modify the fibroblast cell transcriptome or it the 
epithelial cells secreted factors basolaterally in response to IFNT to modify fibroblast cell gene 
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expression. Considering conceptus IFNT can leave the endometrium and travel systemically, it is 
possible that IFNT traveled either paracellularly or transcellular to reach the fibroblast cells [171, 
172].  
 
Classical and Non-Classical ISGs stimulated by IFNT 
Endometrial transcriptomic reported by Forde et al. (2011) of d16 cyclic and pregnant 
heifers consisted largely of classical ISGs including B2M, interferon alpha-inducible protein 6 
(IFI6), ISG15, MX2, MX1, OAS1, and STAT1 [168]. The bovine endometrium has also been 
found to respond earlier than d16 as d8 blastocysts and d15 conceptuses have been documented 
to alter endometrial gene expression in bovine endometrial explants cultured with explants [143, 
153]. The 3D cultured bovine endometrial epithelial and fibroblast cells exhibited a significant 
upregulation of classical ISGs including IFIT1, ISG15, MX2, OAS2, and RSAD2 in response to 
IFNT treatment (Table 3.3). These genes were also recently reported to be up-regulated genes in 
explants treated with IFNT or a conceptus [143]. The gene, RSAD2, is believed to be involved in 
the development of an antiviral endometrial environment via the inhibition of an innate immune 
response [173, 174].   
The role of various classical ISGs is still undetermined. The endometrial up-regulation of 
the classical ISG, ISG15, is associated with infection prevention and is hypothesized to protect 
the developing conceptus from a negative inflammatory response [175]. In sheep, ISG15, IFIT1, 
and RSAD2 have been identified to be up-regulated by IFNT in the endometrial glandular 
epithelium and fibroblast cells after d14 of gestation [41, 42]. This agrees with data from the 
current study as these genes were found to be up-regulated by IFNT in both epithelial and 
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fibroblast cells as well as by the coculture of endometrial explants with an elongating conceptus 
and IFNT.  
Factors, including IFNT and P4, stimulate ovine endometrial genes in a cell-specific 
manner. Expression of IFNT and P4 responsive genes, including the non-classical ISGs, 
LGALS15, and CTSL, were shown to be upregulated in the epithelium by d14/15 of both 
pregnant and cyclic sheep, however, expression then resided by d16 in cyclic sheep. This led to 
the conclusion that LGALS15 and CTSL are stimulated by P4, IFNT extends their expression 
[167, 176]. Bovine and ovine IFNT responsive endometrial genes vary as LGALS15, a gene 
highly upregulated during early pregnancy in sheep is not present in cattle [177].  Non-classical 
ISGs are hypothesized to influence proliferation, migration, attachment, and adhesion of the 
trophectoderm to support elongation of the conceptus [169]. The gene, LGALS3BP, has been 
previously reported to be abundant in both pregnant and cyclic d16 uterine luminal fluid and 
endometrium of heifers in comparison to d13 [138, 168, 178]. Galectin-9 was upregulated in 
epithelial and fibroblast cells in response to IFNT treatment, while LGALS3BP was found to only 
be up-regulated in epithelial cells (Table 3.2). Both LGALS3BP and LGALS9 are also reported as 
being stimulated by a conceptus and IFNT in bovine endometrial explants [143].  During 
implantation, LGALS9 has been suggested to play an immunomodulatory role through the 
regulation of endometrial leukocytes in humans [151]. The recently classified non-classical ISG, 
LGALS9 has been suggested to play an immunomodulatory role through the regulation of 
endometrial leukocytes during human implantation [151]. Through interaction with LGALS3, 
LGALS3BP forms cell aggregates and is involved in cell adhesion [179].  
In the ovine model, IRF2 acts to suppress the transcriptional effects of IFNT on luminal 
epithelial cells, thereby inhibiting the up-regulation of many endometrial classical ISGs [45]. 
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Classical ISGs contain at least a single IFN-stimulated response element (ISRE) in their 
promoter of which IRF2 acts to inhibit transcriptional activity [169]. Induced by IFNT, IRF1 is 
hypothesized to increased classical ISG expression in the stroma. Both IRF1 and IRF2 were up-
regulated in the epithelial cells in response to IFNT (logFC 0.76 and 0.66, respectively; Table 
3.2). 
Members of the family of proteins known as SLC transporters are important during 
conceptus elongation in ruminants as they transport endometrial amino acids into the uterine 
lumen for nourishment [25, 26]. It is believed that the effects of IFNT and P4 trigger an increase 
in amino acids to be transported to the uterine lumen [180]. Solute carrier family 14 member 3 
(SLC15A3) is an amino acid transporter that transports lysosome histidine and peptides and was 
found to be elevated in bovine gestational d18 endometrial tissue [165]. Groebner et al. (2011) 
found mRNA expression of SLC15A3 increased in response to recombinant bovine IFNT 
treatment to cocultured bovine glandular epithelial and stromal cell. The stromal cells exhibited a 
significant 177-fold increase of SLC15A3 while glandular epithelial cells had a 36-fold increase 
[181]. Data from the current study show the up-regulation of SLC15A3 in the epithelial and 
fibroblast cells due to IFNT (logFC 6.29 and 7.06, respectively; Table 3.2). Previously, SLC15A3 
was identified to be IFNT-dependent along with other SLC transporters including the 
mitochondrial transporter of an unknown solute, solute carrier family 25 member 30 
(SLC25A30), and the mitochondrial thiamine pyrophosphate transporters, solute carrier family 25 
member 28 (SLC25A28) and solute carrier family 25 member 19 (SLC25A19) [143]. The 
transporters SLC25A30, SLC25A28, and SLC25A19 were all up-regulated by IFNT in 3D 
cultured epithelial cells in the current study (logFC 1.34, 2.54, and 1.27, respectively; Table 3.2).  
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Despite the apical IFNT treatment to the 3D culture of bovine endometrial epithelial and 
fibroblast cells, IFNT affected fibroblast gene expression as exhibited by the up-regulation of the 
gene ZC3HAV1 in the fibroblast cells alone. The gene, ZC3HAV1, is an ortholog of zinc-finger 
antiviral protein (ZAP) which degrades viral RNA through direct binding [182]. Zinc finger 
CCCH-type antiviral protein 1 has antiviral properties as the CCCH zinc-finger motif binds viral 
RNA directly [183, 184]. Ozawa et al. (2012) identified ZC3HAV1 as a gene that is up-regulated 
in the inner cell mass of d8 in vitro produced blastocysts in comparison to the trophectoderm 
[185]. The role of IFNT induced ZC3HAV1 within bovine endometrial stromal cell is unknown.  
 Forde et al. (2015) found LGALS3 mRNA was expressed by both the d16 endometrium 
and conceptus but was more abundant in the d16 conceptus [178]. Therefore, we attempted to 
test the function of LGALS3 in the bovine endometrium using a 3D cell culture system. Bovine 
endometrial epithelial and fibroblast cells in the 3D culture were treated with 100 and 1000 ng of 
recombinant mouse LGALS3 protein. Compared to Control epithelial cells, epithelial cells 
treated with LGALS3 had greater expression of a single gene, RPL23A (logFC 4.05). However, 
RPL23A gene expression differences were unable to be detected when assayed by using RT-
qPCR (Table 3.6). Six pseudogenes for RPL23A are present in the bovine genome, therefore, it is 
possible we did not amplify the correct transcript by RT-qPCR. The cells that received the lower 
concentration of LGALS3 (100 ng) were analyzed by RNA Seq, we investigated the gene 
expression all samples to examine if the higher dose of LGALS3 (1000 ng) resulted in 
significant gene expression differences.  Of the genes examined, we were unable to detect 
differences between either LGALS3 treatment (100 and 1000 ng) and the Control-treated 
epithelial and fibroblast cells. A previous study successfully utilized recombinant LGALS3 
protein from humans and an unidentified mammal in vitro to elicit a response on cultured bovine 
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luteal cells [118]. However, we conclude that recombinant mouse LGALS3 protein did not elicit 
a cellular response in the bovine cells. Further studies utilizing recombinant bovine LGALS3 
may conclude a role for LGLAS3 during early pregnancy during cattle. Recombinant bovine 
LGALS3 was not available to test the responsiveness of the endometrium cells in experiment 
two, therefore, we treated the cells with uterine FF collected from d14 pregnant sheep. 
Theoretically, the ovine FF contained IFNT produced by the conceptus. The endometrial cells 
treated with the ovine FF did increase the expression of IFNT stimulated genes (ISG15 and 
LGALS3BP; Table 3.6) indicating the cells were responsive. Interestingly, CXCR4 and LIF, 
genes are known to be important for implantation in mammals were also increased in the 
endometrial cells in response to pregnant ovine uterine FF (Table 3.6). The role LGALS3 plays in 
the endometrium and early ruminant embryo requires further investigation.  
 
CONCLUSIONS 
 
 Findings from this study support the utilization of 3D culture of bovine endometrial cells 
to study early conceptus-maternal crosstalk and identify endometrial cell type-specific responses 
to the conceptus. We identified 154 IFNT-responsive genes specifically in the endometrial 
epithelial cells that were previously found to be upregulated in total endometrium treated with 
IFNT and d15 elongating bovine conceptuses [143]. A single gene, ZC3HAV1, also found to be 
upregulated in total bovine endometrium treated with IFNT and d15 bovine conceptuses, was 
upregulated in the fibroblast but not the epithelial cells. Sixty-nine genes were differentially 
expressed in both epithelial and fibroblast cells. Expression of specific IFNT responsive genes 
within specific tissue compartments of the endometrium may have important functions during 
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maternal recognition of pregnancy and placentation in ruminants. The role of IFNT responsive 
genes and uncharacterized conceptus secretory proteins, such as galectins, needs further 
investigation. 
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Table 3.1. GenBank accession number, gene name, primer direction, primer sequence, product
 size, percent amplification efficiency, and source of primer of cDNAs amplified during
 real-time quantitative polymerase chain reaction (RT-qPCR). 
 
GenBank 
Acc. Number 
Gene Primer Primer Sequence (5’-3’) 
Product 
Size 
(bp) 
Amp. 
E. 
(%) 
 
Source 
NM_178320 PPIA Forward CATACAGGTCCTGGCATCTTGTCC 108 -- [153] 
  Reverse CACGTGCTTGCCATCCAACC    
NM_174178 SDHA Forward ACTTCACCGTTGATGGCAA 59 -- [153] 
  Reverse GCAGAAATCGCATCTGAAA    
NM_001040516.1 RPL19 Forward GAAAGGCAGGCATATGGGTA 86 -- [153] 
  Reverse TCATCCTCCTCATCCAGGTT    
NM_174814.2 YWHAZ Forward ACCTACTCCGGACACAGAACATC 65 -- [143] 
  Reverse CCAGTTTGGCCTTCTGTACCA    
NM_001077953.1 RNF11 Forward TCCGGGAGTGTGTGATCTGTATGAT 131 -- [143] 
  Reverse GCAGGAGGGGCACGTGAAGG    
NM_001034034.2 GAPDH Forward TTCTACTGGCGCTGCCAAGG 107 -- [143] 
  Reverse GATCCACAACAGACACGTTGGG    
NM_173979.3 ACTB Forward CAGCAGATGTGGATCAGCAAGC 91 -- [143] 
  Reverse AACGCAGCTAACAGTCCGCC    
NM_001014389.2 H3F3A Forward CATGGCTCGTACAAAGCAGA 136 -- [143] 
  Reverse ACCAGGCCTGTAACGATGAG    
NM_001029846.1 OAS1 Forward CCCGGCGGACCCTACAGGAA 84 95 [168] 
  Reverse TCCAGCCAGACCAAAGCCGC    
 XM_010801645.3 MX1 Forward CGAGCCGAGTTCTCCAAATG 114 96 [153] 
  Reverse CAACTCTCTGCCACGATACC    
NM_001077900.1 STAT1 Forward GCATTAGTCAGGGCCCAAATTGTTACAG 139 96 [153] 
  Reverse GCCAGATACAGGAAGCTTTGCAC    
NM_173941.2 MX2 Forward GGGCAGCGGAATCATCACCCG 102 93 [143] 
  Reverse AGCTGCTGCGTAATGTTGCGGTA    
NM_001015570.3 LGALS9 Forward TCAGCTTCCAGCCTCCAGGG 86 97 [153] 
  Reverse TCCAGGGGCGCTGTGTATGGT    
NM_001046316.2 LGALS3BP Forward CAACTGCAGACACGACAAGG 88 95 [153] 
  Reverse AGGGATTTCGCCAGATAGGT    
NM_174301.3 CXCR4 Forward AAGGCTCAGAAGCGCAAG 102 102 [186] 
  Reverse GAGTCGATGCTGATCCCAAT    
NM_174366.1 ISG15 Forward CCAACCAGTGTCTGCAGAGA 76 97 [143] 
  Reverse CCCTAGCATCTTCACCGTCA    
NM_001024557.1 OAS2 Forward TGGATAACACCTGCTGGCTG 82 93 This Study 
  Reverse GGTCCAGGTGACTCGTTCTG    
NM_001101866.2 IDO1 Forward CACCCCAAAGAAGTTTGCCG 80 99 This Study 
  Reverse GCTGAATGCCCAGGAGAACA    
NM_001114506.1 TNFSF13B Forward GGGACGAACTGAGTCTGGTG 147 96 This Study 
  Reverse TCTTAGCATCTTCCCGGGGT    
XM_005216258.4 MAP6 Forward ATAAGCCAACCCCAGCTGAC 82 110 This Study 
  Reverse GGAGGTTCCTTGAAGGGCTC    
NM_001192561.2 BATF2 Forward ATCTCCTGCACAGCTGTCAC 132 106 This Study 
  Reverse AGGAACTCTAGAGGGGCAGG  
XM_003586006.5 ZC3HAV1 Forward AGGCCTTTTGTGACCCCAAA 119 97 This Study 
  Reverse TGTGACGGATGAAGGTGTGG    
XM_003587616.5 PRRT3 Forward GAGGCCTGGGAAGTCAGTTC 98 97 This Study 
  Reverse GATGGGAGATCTGACGGCTG    
NM_001192640.1 DMRTA1 Forward CACGGCATTAACTTAGCGCC 115 92 This Study 
  Reverse TGACACAATTCCCGCGATGA    
NM_001045958.2 RPL23A Forward ATGAAGATGGCGCCGAAG 110 88 This Study 
  Reverse TGGCTGTGGACACCTTTCAA    
XM_015475541.2 LIF Forward GGGACAACTCAACAGCAGTG 91 96 This Study 
  Reverse GCACAGCTTGTCCAGGTTG    
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Figure 3.1. The 3D cell culture system used to coculture bovine endometrial epithelial and
 fibroblast cells. Epithelial cells were seeded on a transwell insert coated with Matrigel
 (Corning Inc.) and fibroblast cells were located below inserts. The oIFNT or LGALS3
 was administered apically.  
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Figure 3.2. A Venn diagram (Venny 2.1 BioinfoGP) categorizing differentially expressed genes 
(DEGs) in response to oIFNT among bovine endometrial intercaruncular explants and 
bovine endometrial epithelial fibroblast cells cultured in a 3D system. Explants, treated 
with oIFNT and d15 bovine conceptus [143], shared 224 transcripts with endometrial 
epithelial and fibroblast cells. Of those DEGs, 154 were specific to the epithelium while a 
single transcript, ZC3HAV1, was exclusive to the fibroblast cells cultured in the 3D 
system. Explants treated with a conceptus or oIFNT shared 69 transcripts that were 
differentially expressed with both epithelial and fibroblast cells treated with oIFNT. 
I 
II 
III IV 
V VI 
VII 
 72 
Table 3.2. Genes up- or down-regulated in the Venn diagram (Figure 2.1).    
I II III IV 
Up 
GBP2 
GBP6 
SLFN11 
IDO1 
IFITM3 
ACKR4 
TNFSF13B 
MLKL 
MASTL 
SP110 
KIF5C 
IFITM1 
WARS 
FOXS1 
ISG20 
GNGT2 
SLFN12 
APOL3 
TMEM140 
CDADC1 
CD274 
GHSR 
HES4 
CASP4 
BCL2L15 
DRAM1 
IFI35 
FAM212A 
BOLA-DMB 
SASS6 
BPNT1 
MORC3 
GTF2B 
STAT2 
IRF8 
HSH2D 
OPTN 
DAXX 
ATXN3 
GNB4 
RBCK1 
NMI 
PLSCR2 
GDAP2 
MOV10 
STAT1 
ATAD1 
LGALS3BP 
AKAP7 
USP25 
ANXA1 
SLC25A28 
PARM1 
NCOA7 
VCPIP1 
TRIM56 
GRINA 
SPATS2L 
ATP10A 
NLRC5 
CNP 
CBLN3 
ATP8B4 
MAD2L2 
PSMB9 
BCL2L12 
BCL2L14 
PSMB8 
PSMF1 
LEKR1 
NAMPT 
IRF3 
TAP2 
CMTR1 
PAPD4 
SCLY 
NT5C3A 
CDKN2AIP 
RAB8B 
ZNF607 
OGFR 
PSME2 
ANKFY1 
PXK 
PSMA2 
LAP3 
DNAJC1 
SLC25A30 
SERTAD1 
ERAP1 
RIPK3 
STK38L 
TAPBP 
CUL4B 
NR3C1 
RNF19B 
AIDA 
RBBP6 
RNF31 
PAPD7 
SLC25A19 
CCDC82 
IL15RA 
TRIM26 
CCDC6 
TRIM16 
PPP2R3C 
HEATR5B 
IRF2 
FAM111B 
JADE2 
DUSP11 
YTHDC2 
TMEM268 
CHMP5 
PLSCR4 
CTC1 
XPO1 
RBMS2 
NFE2L3 
MAT2B 
TAPBPL 
PRICKLE3 
NUB1 
DNPEP 
KIFC3 
CD47 
RNF139 
B2M 
KAT2A 
AZI2 
MCHR1 
MITD1 
TLR3 
CASP8 
FBXO33 
RICTOR 
ABHD1 
RNF114 
SHISA5 
PLEKHA7 
CDK18 
PDCD4 
POLH 
TRIM38 
C2 
ARSH 
XRN2 
ELMO2 
IRF1 
RAB37 
TMEM106A 
TREX1 
DDX19B 
 
 
 
 
 
 
 
 
 
 
 
 
Up 
MX2 
IFIT3 
RSAD2 
IFIT1 
IFI44 
IFIT2 
ISG15 
GBP4 
IFI44L 
SAMD9 
OAS2 
BST2 
UBA7 
USP18 
ZBP1 
OAS1X 
MX1 
GBP1 
CMPK2 
RTP4 
RNF213 
BATF2 
EPSTI1 
DDX58 
PARP14 
TNFSF10 
HERC6 
IFIH1 
GBP5 
HERC5 
PLAC8 
ZNFX1 
EIF2AK2 
SP100 
IRF4 
DTX3L 
PML 
TRIM5 
IRF9 
IRF7 
TIFA 
XAF1 
PARP12 
IFIT5 
PARP10 
PNPT1 
SLC15A3 
FAM3B 
IFI16 
SP140 
TRANK1 
ADAR 
PLEKHA4 
TRIM34 
CMTR2 
TDRD7 
LGALS9 
PARP9 
IFI6 
RBM43 
UBE2L6 
RNASEL 
TRIM21 
N4BP1 
TAP1 
TRIM25 
DHX58 
CASP7 
IFI27 
 
Up 
ZC3HAV1 
Up 
OAS1Z 
LOC112441507 
OAS1Y 
CCDC194 
SP140L 
LOC107132617 
CGAS 
C7H19orf66 
LOC112446427 
TMPRSS2 
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V VI 
Up 
CLEC4F 
CCL8 
CXCL11 
CXCL10 
TIMD4 
APOBEC3Z1 
OAS1 
GBP7 
GVINP1 
CXCL9 
IFI47 
MYADML 
MB21D1 
SECTM1 
TNFSF13BL 
ISG12B 
LOR 
CYP2J2 
TCF15 
KYNU 
BL37 
P2RY6 
CLEC10A 
CDHR5 
RUBCN 
REC8 
C1ORF109 
ZNF366 
BL36 
TLR4 
EHD3 
LPCAT2 
AGRN 
 
REGAKINE-1 
TMEM74B 
SLC2A6 
BL37L 
C3AR1 
PTPRO 
C21ORF91 
PDCD1 
CD53 
CLEC2D 
POLD3 
TFEC 
C19ORF66 
ABCG2 
STARD8 
MICB 
C3ORF38 
HEG1 
IL23A 
HORMAD1 
IL15 
NEURL3 
PTPN11 
SIGLEC1 
CD40 
PHACTR1 
ACOT9 
TAL1 
FRMD4B 
ACSL5 
TSKU 
ADGRF5 
DECR2 
CTSS 
 
FAM172B 
C4A 
IP6K1 
STOML1 
FAS 
GSDMD 
TLE4 
DYSF 
DYNC1H1 
RAPGEF3 
PARP8 
SYNE2 
PLPP3 
LIFR 
RIPK2 
KYAT3 
ARHGEF3 
SCARF1 
ZC3H12C 
ZCCHC6 
AIFM2 
PSME1 
ZNF628 
TGM2 
PDE5A 
MTO1 
MRPL32 
ECM1 
KIAA1033 
PPFIBP1 
SSAT-1 
FUNDC1 
PPA1 
SLK 
 
TOR1AIP2 
FYTTD1 
IFRG15 
CFLAR 
PAPD5 
VPS13C 
JAK2 
TCEAL1 
USF1 
MIA3 
USP34 
SOCS2 
ABCB7 
DNAJC13 
GAB1 
BID 
MXD1 
TTC9C 
PHF11 
UNC93B1 
LDB2 
PSMA8 
PLA2G16 
CXORF21 
UNC45B 
ART3 
C1ORF115 
NCF1 
IFI27L 
ALS2 
MAN1C1 
C2ORF68 
 
 
 
Down 
KIT 
CHST15 
FAM101B 
PECAM1 
CD93 
AFAP1L1 
FAM124B 
APLNR 
SOX18 
PALD1 
VASH1 
JAG1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Up 
CNGB1 
SAA4 
LYZ3 
PRM1 
SOX10 
LOC781494 
JAKMIP3 
NUGGC 
MUC12 
LOC511617 
OASL 
BIRC7 
LOC787234 
ADGRG7 
IFNL3 
LOC512869 
BVES 
TMPRSS5 
TNFSF4 
SBK3 
ASB5 
CNDP1 
FRAS1 
ACVR1C 
SLCO2B1 
SLC22A10 
OXT 
ODF3L1 
DPY19L2 
LOC512440 
ELMOD1 
TRIM15 
TRPC3 
GPR63 
PCK1 
SYT16 
LOC107132327 
KIF26A 
ABCC11 
ZC3H12D 
MYAML2 
LOC100141258 
IL3RA 
ANKRD35 
LUZP2 
UPB1 
HS3ST1 
SLC9C1 
C1R 
LRIT3 
PLA2G7 
CAPN8 
LOC112445995 
BREH1 
SLC23A2 
TAGAP 
ARHGAP9 
CDHR4 
ABCB5 
IFITM2 
CLDN16 
SULT6B1 
TGM7 
C5 
MESP2 
CD34 
PDCD1LG2 
RPE65 
LOC521656 
LOC512672 
LOC101903126 
LOC101905257 
STAT4 
B3GNT3 
LY6L 
TSPAN32 
ATP8A2 
CLEC2D11 
GOLCA6L22 
ERBB4 
PSCA 
C5H22orf23 
THEM6 
CHST4 
TRIM14 
LOC101905194 
LOC104970178 
TNFRSF9 
LOC112448863 
DSC1 
LOC515697 
LPL 
LOC509972 
LOC112446668 
SCNN1B 
GMNC 
LOC616948 
SLC13A5 
ANKRD53 
CCDC190 
LOC530929 
LOC101902154 
CPLX1 
LOC112444847 
ISG12(B) 
BST1 
TACR1 
PLA2R1 
OVCH1 
LOC512323 
CSPG5 
TAF4B 
IL34 
LOC782527 
WDR17 
SOCS1 
SCN9A 
ADAM19 
CYP2S1 
JPH2 
RAB19 
KRT42 
MYO1A 
VWA5A 
FAM71A 
ARID3C 
IQCD 
GANC 
COX7A1 
RIPOR3 
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VI Cont. 
Up 
MASP1 
SIX1 
CCDC39 
SCNN1G 
ZCCHC2 
PMAIP1 
TM6SF2 
EPHX2 
FBXO16 
PGR 
INPP5F 
IQUB 
NFIX 
ORC5 
TCTN3 
EHD4 
OVOL1 
CATSPERE 
CIITA 
RAD21L1 
BTC 
LOC515736 
GDA 
DUSP15 
PLIN2 
ZFP36 
IL22RA1 
FBXO45 
LOC618733 
ICA1L 
HSPB11 
APOBEC1 
DDIT3 
DRAM2 
FLT3LG 
IL18 
FAM172BP 
NKX3-1 
LY6E 
BOLA-NC1 
SFN 
TMEM171 
FUT10 
PLA2G3 
MISP 
CALCOCO2 
ERAP2 
CCDC102A 
CSDC2 
ZUP1 
ARL6IP1 
NEB 
LOC508153 
CTSL 
WDR86 
VAMP5 
SAMHD1 
C16H1orf115 
AP5B1 
ICAM1 
ICAM2 
INA 
CHST1 
TACR3 
FOXQ1 
GABRP 
THEM4 
DENND2D 
GRAMD1C 
ALDH9A1 
CROT 
CSRNP1 
TACSTD2 
CLDN1 
CLSTN2 
FAM192A 
YARS 
FAM129A 
AKAP6 
ZNF852 
LIPA 
MTR 
SAT1 
TATDN3 
BSPRY 
ALPK1 
NOSTRIN 
XRCC5 
C1H3orf38 
SIDT2 
CSRNP2 
LENG1 
TCAF2 
RBMX2 
MST1R 
MUC1 
SLC27A1 
UTP23 
HK2 
SEMA4A 
FCHSD2 
LOC518495 
A2ML1 
TRAPPC2 
LYPD6B 
PRKAR1B 
ZDHHC14 
TICRR 
TRMT13 
CPOX 
ITPR2 
WIPF3 
GIPC2 
DCK 
SLC6A12 
ATP7A 
TMEM41A 
GABARAPL1 
SLC25A12 
CAMK2D 
APOBEC3H 
OSMR 
LNPEP 
TMEM144 
FAM76A 
MOCS1 
UBIAD1 
ACP2 
AP1AR 
EVA1A 
C11H2orf68 
PPAT 
BTBD11 
BOLA 
HACD2 
ACOX3 
FBXO7 
ARL6IP5 
SARS 
RFX5 
TAF5 
APRT 
STXBP3 
ZNF197 
SERINC2 
PSMB10 
PRKD2 
S1PR2 
DDX24 
GCHFR 
C16H1orf112 
ELF1 
RRM2B 
HNF4G 
TWISTNB 
ID4 
LOC101905041 
B4GALT1 
EMP1 
ACSS2 
PCGF5 
ADM2 
SNX4 
VPS33B 
POLR2K 
CGN 
HKDC1 
ADPGK 
DNAJA1 
HFE 
RNF39 
DBNL 
MTPAP 
DNMT1 
TPRKB 
EIF2AK1 
SPTY2D1 
GALM 
SLC1A5 
COA7 
TMEM255B 
MTFP1 
PRMT9 
TTC4 
FYB2 
TSPYL1 
PALM 
SARNP 
STARD3 
DNAJC7 
TXNRD1 
RCBTB1 
SEPT7 
GYG1 
TMEM230 
NECTIN2 
AVEN 
BIRC3 
MOCOS 
GPHN 
PLEKHO1 
SCO1 
APOPT1 
FPGT 
WDR18 
F2R 
TMED8 
SCP2 
TCOF1 
MIER3 
MRPL44 
RNF135 
DENND4C 
OSBPL8 
SNX6 
CENPO 
SEC24B 
PRPSAP1 
NISCH 
SSBP3 
ANAPC11 
STRIP1 
FAM110C 
JDP2 
PJA2 
MARCKSL1 
CBLL1 
STAMBP 
KAT5 
ZNF710 
HGH1 
CEPT1 
GTPBP2 
TIPARP 
CSTF1 
ACADM 
MTMR4 
SPPL2A 
PDK3 
ZCCHC8 
SLC35C1 
NARS 
KAT2B 
DESI1 
HAUS3 
PRKAB1 
FGD4 
ARHGEF16 
ZMYM1 
CNOT9 
UHRF2 
DNAJC8 
KCTD9 
PELI1 
MCL1 
FAM168B 
HNRNPLL 
KRT7 
TRIM4 
 
Down 
DESI2 
MBTPS1 
GNPAT 
GTF2A1 
ZDHHC23 
PSD4 
PKD1 
SESN3 
ENTR1 
NETO2 
NBEAL2 
SRD5A1 
VPS33A 
MLEC 
MEGF9 
NAV2 
UNC5B 
TUBB3 
SAMD1 
BCAT1 
ARVCF 
PPARA 
PIAS2 
MTFR1 
TUBA1A 
PTCH1 
EML1 
AKAP12 
LMCD1 
ETV4 
ALDH1A3 
FITM2 
SLC25A15 
KLF13 
SCRN1 
FAM92A 
GVQW3 
PCDHA5 
ZMYND10 
HIST1H3A 
MAP6 
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Table 3.3. The logFC of the top 20 genes up-regulated in bovine endometrial epithelial cells and 
shared with explants treated with oIFNT and a d15 conceptus [143] (I and II of Figure 2.2). 
The fibroblast cell logFC is listed if the gene was also up-regulated in fibroblast cells. 
  
 
GenBank Acc. 
Number 
Gene 
Epithelial 
Cell LogFC 
Fibroblast 
Cell LogFC 
XM_005227105.4 BATF2 11.88 2.80 
XM_015473641.2 MX2 10.26 7.83 
XM_002686295.6 IFI44 9.95 7.63 
XM_015460598.2 IFIT1 9.65 3.56 
NM_001024557.1 OAS2 9.51 9.63 
XM_024993137.1 PLAC8 8.96 7.75 
NM_001076127.2 KIF5C 8.66 -- 
XM_015474249.2 ZBP1 8.47 8.06 
NM_001045941.1 RSAD2 8.46 8.35 
NM_001075414.1 IFIT3 8.15 3.36 
NM_174366.1 ISG15 7.94 6.90 
XM_003586247.5 HSH2D 7.86 -- 
XM_024981673.1 IFI27 7.85 5.03 
XM_024998051.1 ATP8B4 7.52 -- 
XM_015471926.2 BST2 7.25 6.47 
NM_001101866.2 IDO1 7.18 -- 
NM_001099716.1 FOXS1 7.17 -- 
XM_003585891.5 IFI44L 7.09 8.66 
NM_001206162.1 IRF4 6.97 5.73 
NM_178108.2 OAS1X 6.78 7.35 
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Table 3.4. Gene ontology (GO) Biological Process Direct for 223 genes up-regulated in bovine
 endometrial epithelial cells treated with 100 ng of oIFNT in 3D culture (I and II of Figure
 2.2).   
Term P-Value Genes 
GO Biological Process Direct   
Type I interferon signaling 
pathway < 0.001 
RNASEL, IFITM1, IFITM3, RSAD2, OAS2, IFI35, ISG20, ISG15, XAF1, 
MX1, MX2, SP100, BST2, STAT1, PSMB8, STAT2, IFIT3, IRF9, IFIT2, 
IFIT1, IFI27, IRF7, IRF8, IRF1, IRF2, IRF3, IRF4, GBP2, IFI6, ADAR 
Defense response to virus < 0.001 
 
RNASEL, IFITM1, IFITM3, PML, TLR3, RSAD2, IFI44L, OAS2, ISG20, 
TRIM5, NLRC5, ISG15, MX1, MX2, DHX58, BST2, HERC5, TRIM25, 
IFI16, STAT1, STAT2, IRF9, IFIT3, TRIM56, IFIT2, IFIT1, TRIM34, IFIT5, 
IRF1, IRF3, SLFN11, EIF2AK2, GBP1, ADAR 
 
Interferon-gamma-mediated 
signaling pathway < 0.001 
 
SP100, NMI, PML, TRIM26, TRIM25, OAS2, STAT1, TRIM21, B2M, IRF9, 
TRIM38, TRIM5, TRIM34, IRF7, IRF8, IRF1, IRF2, IRF3, IRF4, GBP2, 
GBP1 
Response to virus < 0.001 
 
IFIH1, BST2, IFITM1, IFITM3, RSAD2, IFI44, OAS2, ISG20, DDX58, 
PSMA2, IFIT3, IFIT2, IFIT1, IRF7, EIF2AK2, MX1, MX2, DHX58, ADAR 
 
Negative regulation of viral 
genome replication < 0.001 
RNASEL, IFITM1, BST2, IFITM3, RSAD2, PARP10, IFI16, ISG20, IFIT1, 
ISG15, EIF2AK2, MX1, ADAR 
 
Negative regulation of type I 
interferon production < 0.001 
DDX58, NLRC5, IFIH1, ISG15, HERC5, UBA7, UBE2L6, TRIM25, IRF3, 
DHX58 
Innate immune response < 0.001 
 
IFIH1, BST2, ANXA1, PML, HERC5, TLR3, TRIM26, TRIM25, IFI16, 
TRIM21, B2M, DDX58, NLRC5, TRIM5, CASP4, IFIT5, IRF7, C2, 
EIF2AK2, MX1, MX2, DHX58, ADAR, ZBP1 
Protein polyubiquitination < 0.001 
 
DTX3L, HERC6, HERC5, RBBP6, RNF213, TRIM21, PSMB8, PSMB9, 
PSMA2, PSMF1, RNF114, PSME2, RNF139, RBCK1, RNF19B, RNF31 
 
Response to interferon-alpha < 0.001 BST2, IFITM1, IFITM3, EIF2AK2, MX2, ADAR 
 
Antigen processing and 
presentation of endogenous 
peptide antigen via MHC class 
I < 0.001 TAP2, TAP1, ERAP1, TAPBP, B2M 
 
Response to interferon-beta < 0.001 BST2, IFITM1, IFITM3, XAF1, STAT1 
 
Positive regulation of I-kappa 
b kinase/NF-kappa b signaling < 0.001 
TRIM5, APOL3, TRIM38, TNFSF10, BST2, CASP8, SHISA5, RBCK1, 
TRIM25, IRF3, LGALS9, RNF31 
 
Response to interferon-gamma < 0.001 SP100, BST2, IFITM1, NUB1, IFITM3, TRIM21 
Positive regulation of 
interferon-beta production < 0.001 DDX58, IFIH1, IRF7, IRF1, TLR3, IRF3 
 
Negative regulation of viral 
release from host cell < 0.001 TRIM5, PML, TRIM26, TRIM25, TRIM21 
 
ISG15-protein conjugation < 0.001 ISG15, HERC5, UBA7, UBE2L6 
 < 0.001 TRIM5, IFITM1, IFITM3, TRIM26, TRIM25 
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Negative regulation of viral 
entry into host cell 
 
Response to type I interferon < 0.001 TRIM56, SP100, ISG15, MX1 
Apoptotic process < 0.001 
 
BCL2L15, BCL2L14, FAM3B, PML, NR3C1, STAT1, BCL2L12,  
DAXX, PDCD4, ELMO2, TNFSF10, CASP4, CASP7, CASP8,  
IRF1, IRF3, XAF1, MX1, DRAM1 
 
Positive regulation of NF-
kappa b transcription factor 
activity < 0.001 
TRIM5, TRIM38, RIPK3, RBCK1, TLR3, TRIM25, EIF2AK2, LGALS9, 
RNF31 
 
Positive regulation of 
sequence-specific DNA 
binding transcription factor 
activity < 0.001 DDX58, TRIM5, TRIM38, SP100, TRIM34, TRIM26, TRIM25, TRIM21 
 
Positive regulation of 
interferon-alpha production < 0.001 DDX58, IFIH1, IRF7, IRF3 
 
Positive regulation of type I 
interferon production < 0.001 IRF7, IRF1, IRF3, IFI16, DHX58, ZBP1 
   
MDA-5 signaling pathway < 0.001 IFIH1, IRF7, IRF3 
 
Antigen processing and 
presentation of peptide antigen 
via MHC class I < 0.001 TAP2, TAP1, ERAP1, TAPBP, B2M 
 
Regulation of type I interferon 
production < 0.001 TRIM56, IRF7, TREX1, TRIM21 
 
I-kappa b kinase/NF-kappa b 
signaling 0.001 RIPK3, RBCK1, TIFA, TLR3, AZI2, RNF31 
 
Proteasome-mediated 
ubiquitin-dependent protein 
catabolic process 0.001 
PSMA2, PSMF1, TRIM38, ATXN3, PSME2, RNF139, PML, RBCK1, 
PSMB8, PSMB9 
 
Regulation of activated T cell 
proliferation 0.001 CD274, RIPK3, IDO1 
 
Cellular response to 
interferon-beta 
 
 
0.001 
 
 
PNPT1, IRF1, TLR3, STAT1 
 
Translesion synthesis 0.001 POLH, ISG15, UBA7, UBE2L6, TRIM25 
 
Antigen processing and 
presentation of exogenous 
peptide antigen via MHC class 
I, TAP-dependent 0.001 PSMA2, PSMF1, PSME2, PSMB8, PSMB9, B2M 
 
NIK/NF-kappab signaling 0.001 PSMA2, PSMF1, PSME2, RIPK3, PSMB8, PSMB9 
 0.001 ISG15, UBA7, UBE2L6 
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Modification-dependent 
protein catabolic process 
 
Detection of virus 0.001 DDX58, IFIH1, TLR3 
 
Intracellular transport of viral 
protein in host cell 0.001 IFIT1, TAP2, TAP1 
 
Regulation of mRNA stability 0.001 PSMA2, PSMF1, XPO1, RNASEL, PSME2, PSMB8, PSMB9 
 
RNA catabolic process 0.002 PNPT1, OAS2, XRN2, ISG20 
 
Regulation of adaptive 
immune response 0.002 IRF7, RIPK3, IRF1 
 
Positive regulation of viral 
entry into host cell 0.003 TRIM38, LGALS9, TRIM21 
 
Antigen processing and 
presentation of exogenous 
protein antigen via MHC class 
Ib, TAP-dependent 0.003 TAP2, TAP1, B2M 
 
Tumor necrosis factor-
mediated signaling pathway 0.003 PSMA2, PSMF1, TNFSF13B, PSME2, STAT1, PSMB8, PSMB9 
 
Regulation of cellular amino 
acid metabolic process 0.003 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Response to cytokine 0.003 IFI27, SP100, CD274, PML, STAT1 
 
Positive regulation of extrinsic 
apoptotic signaling pathway 0.004 TNFSF10, BCL2L14, PML, RBCK1 
TRIF-dependent toll-like 
receptor signaling pathway 
 
 
0.004 IRF7, CASP8, TLR3, IRF3 
 
Protein trimerization 
 
0.005 
 
TRIM5, TRIM34, TRIM21 
 
Positive regulation of type I 
interferon-mediated signaling 
pathway 0.005 NLRC5, IRF7, IRF3 
 
RNA processing 0.006 PNPT1, RBMS2, YTHDC2, DUSP11, XRN2, ADAR 
 
Ubiquitin-dependent protein 
catabolic process 0.006 PSMA2, PSMF1, ATXN3, USP18, NUB1, CUL4B, USP25, RNF213 
 
JAK-STAT cascade 0.006 NMI, IL15RA, STAT1, STAT2 
 
Negative regulation of innate 
immune response 0.007 NMI, IFI16, DHX58 
 
T cell receptor signaling 
pathway 
 
 
 
0.009 
 
 
 
PSMA2, PSMF1, PSME2, RBCK1, PSMB8, PSMB9, RNF31 
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Viral process 0.010 
 
KAT2A, XPO1, SP100, MORC3, RBCK1, SP110, DAXX, GTF2B, PSMB8, 
PSMB9 
 
Regulation of innate immune 
response 0.010 IRF1, ERAP1, DHX58 
 
Negative regulation of viral 
transcription 0.010 SP100, IFITM3, TRIM21 
 
Negative regulation of 
ubiquitin-protein ligase 
activity involved in mitotic 
cell cycle 0.010 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Immune response 0.013 
 
GBP6, TNFSF10, TNFSF13B, IFITM3, CD274, IRF8, ACKR4, OAS2, GBP2, 
IFI6, TAPBP, B2M 
 
Positive regulation of 
ubiquitin-protein ligase 
activity involved in regulation 
of mitotic cell cycle transition 0.013 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Histone H3 acetylation 0.015 KAT2A, JADE2, TRIM16, IRF4 
 
Anaphase-promoting 
complex-dependent catabolic 
process 0.015 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Regulation of extrinsic 
apoptotic signaling pathway 
via death domain receptors 0.017 TNFSF10, SP100, CASP8 
 
T cell activation 0.019 CASP8, IRF4, AZI2, HSH2D 
 
Necroptotic process 
 
0.019 
 
RIPK3, TLR3, MLKL 
 
Proteolysis involved in 
cellular protein catabolic 
process 0.020 PSMA2, CASP8, PSMB8, PSMB9 
 
Defense response to protozoan 0.021 BATF2, IRF8, IRF4 
 
Regulation of myd88-
dependent toll-like receptor 
signaling pathway 0.024 IRF7, IRF1 
 
Cytosol to ER transport 0.024 TAP2, TAP1 
 
Organelle fission 0.024 MX1, MX2 
 
Interferon-alpha production 0.024 IRF7, AZI2 
 
Regulation of type III 
interferon production 
 
 
0.024 
 
 
DDX58, IFIH1 
 0.024 XRN2, ISG20 
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DNA catabolic process, 
exonucleolytic 
 
Wnt signaling pathway, planar 
cell polarity pathway 0.025 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Positive regulation of NF-
kappa b import into nucleus 0.026 RBCK1, TLR3, LGALS9 
 
Cellular response to 
interferon-gamma 0.031 GBP6, GBP5, TLR3, LGALS9 
 
Myeloid cell differentiation 0.033 IRF8, PML, IFI16 
 
Protein K48-linked 
deubiquitination 0.033 ATXN3, USP25, VCPIP1 
 
Regulation of interferon-
gamma production 0.035 ISG15, RIPK3 
 
Cytoplasmic pattern 
recognition receptor signaling 
pathway in response to virus 0.035 DDX58, IFIH1 
 
Zonula adherens maintenance 
 
 
 
0.035 
 
 
 
PLEKHA7, KIFC3 
 
Interferon-beta production 0.035 TRIM56, IRF7 
 
Response to tumor necrosis 
factor 0.036 NUB1, CASP8, YTHDC2 
 
Positive regulation of 
interleukin-12 production 0.036 IRF8, TLR3, IDO1 
 
Protein ubiquitination 
involved in ubiquitin-
dependent protein catabolic 
process 0.037 HERC6, HERC5, TRIM25, CUL4B, RNF19B, RBBP6 
 
Stimulatory C-type lectin 
receptor signaling pathway 0.037 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Positive regulation of viral 
genome replication 0.038 TRIM38, IFIT1, ADAR 
 
Regulation of type I 
interferon-mediated signaling 
pathway 0.038 USP18, STAT1, STAT2 
 
Inflammatory response 0.039 APOL3, NMI, CASP4, SP100, GBP5, ANXA1, TLR3, IFI16, PXK, LGALS9 
 
Cellular response to DNA 
damage stimulus 0.039 CDKN2AIP, IRF7, DTX3L, IRF3, MASTL, RBBP6, CTC1 
 0.044 PNPT1, XRN2, ISG20 
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RNA phosphodiester bond 
hydrolysis, exonucleolytic 
 
Double-strand break repair 0.045 PARP9, DTX3L, PAPD7, MAD2L2 
 
Defense response 0.046 TAP1, MX1, MX2, SP140 
 
Negative regulation of 
canonical Wnt signaling 
pathway 0.047 PSMA2, PSMF1, PSME2, MAD2L2, PSMB8, PSMB9 
 
Protein linear 
polyubiquitination 0.047 RBCK1, RNF31 
 
Positive regulation of 
interleukin-10 secretion 0.047 CD274, LGALS9 
 
Type I interferon biosynthetic 
process 0.047 IRF7, IRF3 
Regulation of tumor necrosis 
factor-mediated signaling 
pathway 
 
 
0.050  CASP8, RBCK1, RNF3  
KEGG Pathways   
Influenza A < 0.001 
XPO1, IFIH1, RNASEL, PML, TLR3, RSAD2, TRIM25, OAS2, STAT1, 
STAT2, DDX58, IRF9, TNFSF10, IRF7, IRF3, EIF2AK2, MX1, ADAR 
Herpes simplex infection < 0.001 
 
RNASEL, IFIH1, SP100, PML, TLR3, OAS2, STAT1, DAXX, STAT2, 
DDX58, IRF9, IFIT1, IRF7, TAP2, CASP8, TAP1, IRF3, EIF2AK2 
Hepatitis C < 0.001 
 
DDX58, IRF9, RNASEL, IFIT1, IRF7, IRF1, TLR3, IRF3, OAS2, EIF2AK2, 
STAT1, STAT2 
Measles < 0.001 
 
DDX58, IRF9, IFIH1, TNFSF10, IRF7, IRF3, OAS2, EIF2AK2, MX1, 
STAT1, STAT2, ADAR 
RIG-I-like receptor signaling 
pathway < 0.001 DDX58, IFIH1, ISG15, IRF7, CASP8, TRIM25, IRF3, AZI2, DHX58 
 
Cytosolic DNA-sensing 
pathway < 0.001 DDX58, IRF7, RIPK3, TREX1, IRF3, ZBP1, ADAR 
 
Hepatitis B 0.002 DDX58, IFIH1, IRF7, CASP8, TLR3, IRF3, STAT1, STAT2 
Proteasome 0.002 PSMA2, PSMF1, PSME2, PSMB8, PSMB9 
 
Viral carcinogenesis 0.010 KAT2A, IRF9, SP100, IRF7, CASP8, IRF3, EIF2AK2, GTF2B 
Pertussis 0.012 CASP7, IRF8, IRF1, IRF3, C2 
Antigen processing and 
presentation 
 
 
0.012 
 
 
PSME2, TAP2, TAP1, TAPBP, B2M 
Toll-like receptor  
signaling pathway 0.036 IRF7, CASP8, TLR3, IRF3, STAT1 
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Table 3.5. Gene ontology (GO) Biological Process Direct for (70) genes up-regulated in bovine 
endometrial fibroblast cells treated with 100 ng of oIFNT in 3D culture (II and III of Figure 2.2.).  
  
 
Term P-Value Genes 
GO Biological Process Direct   
Defense response to virus < 0.001 
RNASEL, ZC3HAV1, BST2, PML, HERC5, RSAD2, TRIM25, 
IFI44L, OAS2, IFI16, IRF9, IFIT3, IFIT2, TRIM5, IFIT1, ISG15, 
TRIM34, IFIT5, EIF2AK2, MX1, MX2, DHX58, GBP1, ADAR 
Type I interferon signaling pathway < 0.001 
 
RNASEL, SP100, BST2, RSAD2, OAS2, IRF9, IFIT3, IFIT2, 
IFIT1, IFI27, ISG15, IRF7, IRF4, XAF1, MX1, MX2, IFI6, ADAR 
Response to virus < 0.001 
 
IFIH1, BST2, ZC3HAV1, RSAD2, IFI44, OAS2, DDX58, IFIT3, 
IFIT2, IFIT1, IRF7, EIF2AK2, MX1, MX2, DHX58, ADAR 
Negative regulation of viral genome 
replication < 0.001 
 
RNASEL, IFIT1, ISG15, ZC3HAV1, BST2, RSAD2, IFI16, 
PARP10, EIF2AK2, MX1, ADAR 
Interferon-gamma-mediated signaling 
pathway < 0.001 
 
IRF9, TRIM5, SP100, TRIM34, IRF7, PML, TRIM25, OAS2, IRF4, 
TRIM21, GBP1 
Innate immune response < 0.001 
 
IFIH1, BST2, ZC3HAV1, PML, HERC5, TRIM25, IFI16, TRIM21, 
DDX58, TRIM5, IFIT5, IRF7, EIF2AK2, MX1, MX2, DHX58, 
ADAR, ZBP1 
Negative regulation of type I 
interferon production < 0.001 
 
 
DDX58, IFIH1, ISG15, HERC5, UBA7, UBE2L6, TRIM25, 
DHX58 
ISG15-protein conjugation < 0.001 
 
ISG15, HERC5, UBA7, UBE2L6 
Response to interferon-alpha < 0.001 
 
BST2, EIF2AK2, MX2, ADAR 
Positive regulation of interferon-alpha 
production < 0.001 
 
 
DDX58, IFIH1, ZC3HAV1, IRF7 
Negative regulation of viral release 
from host cell < 0.001 
 
 
TRIM5, PML, TRIM25, TRIM21 
Positive regulation of type I interferon 
production < 0.001 
 
 
ZC3HAV1, IRF7, IFI16, DHX58, ZBP1 
Positive regulation of sequence-
specific DNA binding transcription 
factor activity < 0.001 
 
 
 
 
DDX58, TRIM5, SP100, TRIM34, TRIM25, TRIM21 
Positive regulation of interferon-beta 
production < 0.001 
 
 
DDX58, IFIH1, ZC3HAV1, IRF7 
Modification-dependent protein 
catabolic process < 0.001 
 
 
ISG15, UBA7, UBE2L6 
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Response to type I interferon < 0.001 
 
SP100, ISG15, MX1 
Positive regulation of I-kappa b 
kinase/NF-kappa b signaling 
 
 
< 0.001 
 
 
TRIM5, TNFSF10, ZC3HAV1, BST2, TRIM25, LGALS9 
Translesion synthesis < 0.001 
 
ISG15, UBA7, UBE2L6, TRIM25 
 
Protein trimerization < 0.001 
 
TRIM5, TRIM34, TRIM21 
 
Defense response 0.002 TAP1, MX1, MX2, SP140 
Response to interferon-gamma 0.003 
 
SP100, BST2, TRIM21 
Protein polyubiquitination 0.004 DTX3L, HERC6, HERC5, RNF213, TRIM21 
Regulation of type III interferon 
production 0.007 DDX58, IFIH1 
Organelle fission 0.007 MX1, MX2 
Cytoplasmic pattern recognition 
receptor signaling pathway in 
response to virus 0.011 DDX58, IFIH1 
MDA-5 signaling pathway 0.011 IFIH1, IRF7 
Positive regulation of NF-kappa b 
transcription factor activity 0.013 TRIM5, TRIM25, EIF2AK2, LGALS9 
Response to cytokine 0.015 IFI27, SP100, PML 
Peptide transport 0.018 TAP1, SLC15A3 
Detection of virus 0.018 DDX58, IFIH1 
Intracellular transport of viral protein 
in host cell 0.018 IFIT1, TAP1 
Positive regulation of viral entry into 
host cell 0.025 LGALS9, TRIM21 
 
Positive regulation of RIG-I signaling 
pathway 0.029 ZC3HAV1, DHX58 
Cellular response to interferon-alpha 0.032 IFIT3, IFIT2 
Response to interferon-beta 0.032 BST2, XAF1 
Activation of innate immune response 0.036 TRIM5, IFI16 
Activation of cysteine-type 
endopeptidase activity involved in 
apoptotic process 0.037 IFI27, TNFSF10, PML 
Negative regulation of innate immune 
response 0.039 IFI16, DHX58 
Positive regulation of mRNA 
catabolic process 0.043 ZC3HAV1, PNPT1 
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Regulation of type I interferon 
production 0.046 IRF7, TRIM21 
Cellular response to virus 0.046 LGALS9, ADAR 
Cellular response to exogenous 
dsRNA 0.046 IFIT1, ZC3HAV1 
Negative regulation of viral 
transcription  0.046  SP100, TRIM21  
KEGG Pathways Column3 Column4 
 
Influenza A 
 
< 0.001 
IFIH1, RNASEL, PML, RSAD2, TRIM25, OAS2, IRF9, DDX58, 
TNFSF10, IRF7, EIF2AK2, MX1, ADAR  
 
Herpes simplex infection 
 
< 0.001 
DDX58, IRF9, RNASEL, IFIT1, IFIH1, SP100, IRF7, TAP1, PML, 
OAS2, EIF2AK2  
 
Measles 
 
< 0.001 
DDX58, IRF9, IFIH1, TNFSF10, IRF7, OAS2, EIF2AK2, MX1, 
ADAR 
 
RIG-I-like receptor signaling pathway 
 
 
< 0.001 DDX58, IFIH1, ISG15, IRF7, TRIM25, DHX58 
 
Hepatitis C 
 
< 0.001 DDX58, IRF9, RNASEL, IFIT1, IRF7, OAS2, EIF2AK2 
 
Cytosolic DNA-sensing pathway 0.002 DDX58, IRF7, ZBP1, ADAR 
 
Viral carcinogenesis 0.037 IRF9, SP100, IRF7, EIF2AK2 
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Figure 3.3. Quantitative real-time PCR analysis of MX1 gene expression in bovine endometrial
 (A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media
 only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized
 over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM
 ± SEM. Relative expression of MX1 was greater in epithelial and fibroblast cells treated
 with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.4. Quantitative real-time PCR analysis of MX2 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized 
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM 
± SEM. Relative expression of MX2 was greater in epithelial and fibroblast cells treated 
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.5. Quantitative real-time PCR analysis of OAS1 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 n ng/mL of oIFNT (n=3). Relative expression data are 
normalized over the geometric mean of reference genes, RNF11 and SDHA. Data are 
presented as LSM ± SEM. Relative expression of OAS1 was greater in epithelial and 
fibroblast cells treated with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.6. Quantitative real-time PCR analysis of LGALS3BP gene expression in bovine 
endometrial (A) epithelial and (B) fibroblast cells cultured in 3D treated with either 
treatment media only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression 
data are normalized over the geometric mean of reference genes, RNF11 and SDHA. Data 
are presented as LSM ± SEM.Relative expression of LGALS3BP was greater in epithelial 
and fibroblast cells treated with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.7. Quantitative real-time PCR analysis of LGALS9 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized 
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM 
± SEM. Relative expression of LGALS9 was greater in epithelial and fibroblast cells treated 
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.8. Quantitative real-time PCR analysis of OAS2 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized 
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM 
± SEM. Relative expression of OAS2 was greater in epithelial and fibroblast cells treated 
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.9. Quantitative real-time PCR analysis of BATF2 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized 
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM 
± SEM. Relative expression of BATF2 was greater in epithelial and fibroblast cells treated 
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.10. Quantitative real-time PCR analysis of IDO1 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized 
over the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM 
± SEM. Expression of IDO1 was not significantly elevated in oIFNT treated epithelial and 
fibroblast cells (P > 0.05).   
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Figure 3.11. Quantitative real-time PCR analysis of MAP6 gene expression in bovine endometrial 
(A) epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media 
only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are 
normalized over the geometric mean of reference genes, RNF11 and SDHA. Data are 
presented as LSM ± SEM. Expression of MAP6 decreated in oIFNT treated epithelial 
cells, however, not statistically (P > 0.05). In the fibroblast cells, there was not a trend (P 
> 0.05).   
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Figure 3.12. Quantitative real-time PCR analysis of TNFSF13B gene expression in bovine (A) 
epithelial and (B) fibroblast cells cultured in 3D treated with either treatment media only 
(Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression data are normalized over 
the geometric mean of reference genes, RNF11 and SDHA. Data are presented as LSM ± 
SEM. Relative expression of TNFSF13B was greater in epithelial and fibroblast cells treated 
with oIFNT (***P < 0.001; **P < 0.01; *P < 0.05). 
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Figure 3.13. Quantitative real-time PCR analysis of ZC3HAV1 gene expression in bovine 
endometrial (A) epithelial and (B) fibroblast cells cultured in 3D treated with either 
treatment media only (Control; n=4) or 100 ng/mL of oIFNT (n=3). Relative expression 
data are normalized over the geometric mean of reference genes, RNF11 and SDHA. Data 
are presented as LSM ± SEM. The treatment of endometrial cells with oIFNT significantly 
increased ZC3HAV1 expression exclusively in the fibroblast cells in comparison to the 
control-treated cells. Expression of ZC3HAV1 was not different in epithelial cells (P > 0.05) 
(***P < 0.001; **P < 0.01; *P < 0.05).  
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Table 3.6. Quantitative real-time PCR analysis of the effect of 100 or 1000 ng of recombinant 
mouse LGALS3 protein on 3D cultured epithelial and fibroblast cells. The effect of flush 
fluid of a d14 pregnant ewe (FF) on epithelial and fibroblast cells gene expression was also 
examined. Control cells received treatment media only. Relative expression data are 
normalized over the geometric mean of reference genes, PPIA and SDHA. Data are 
presented as LSM ± SEM.  
 
Gene 
Cell 
Type 
Control FF 
LGALS3 
(100 ng) 
 
LGALS3 
(1000 ng) 
 
Trt. Contrast 
RPL23A Epi. 1.44 ± 0.11 0.93 ± 0.12 1.04 ± 0.11 0.99 ± 0.11 NS NS 
 Fib. 1.07 ± 0.10  1.20 ± 0.11 1.02 ± 0.10 0.83 ± 0.10 NS NS 
CXCR4 Epi. 5.12 ± 0.98a 9.50 ± 1.10b 4.89 ± 0.98a 4.56 ± 0.98a < 0.05 NS 
 Fib. 0.19 ± 0.10 0.41 ± 0.11 0.16 ± 0.20 0.17 ± 0.10 NS NS 
DMRTA1 Epi. 1.80 ± 0.38 1.12 ± 0.42 1.70 ± 0.38 1.33 ± 0.38 NS NS 
 Fib. 1.78 ± 0.45 1.38 ± 0.50 1.28 ± 0.45 1.41 ± 0.45 NS NS 
ISG15 Epi. 0.50 ± 5.31a 130.27 ± 5.94b 0.60 ± 5.31a 0.55 ± 5.31a < 0.001 NS 
 Fib. 0.27 ± 7.70a 58.40 ± 8.61b 0.23 ± 7.70a 0.19 ± 7.70a < 0.001 NS 
LGALS3BP Epi. 0.98 ± 0.16a 4.12 ± 0.18b 1.05 ± 0.16a 1.02 ± 0.16a < 0.001 NS 
 Fib. 0.73 ± 0.21a 1.77 ± 0.23b 0.58 ± 0.21a 0.59 ± 0.21a < 0.01 NS 
LIF Epi. 4.27 ± 0.77a 7.11 ± 0.86b 4.89 ± 0.77a 4.56 ± 0.77a NS NS 
 Fib. 0.27 ± 0.09 0.27 ± 0.10 0.24 ± 0.09 0.23 ± 0.09 NS NS 
PRRT3 Epi. 0.62 ± 0.09 0.47 ± 0.10 0.62 ± 0.09 0.57 ± 0.09 NS NS 
 Fib. 2.62 ± 0.83 2.49 ± 0.93 2.08 ± 0.83 1.87 ± 0.83 NS NS 
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Figure 3.14. Model for IFNT regulation of classical and non-classical up-regulated ISGs in the 
bovine endometrium during early pregnancy. The conceptus secretes IFNT which results 
in the differential expression of endometrial ISGs. The genes listed were the top 10 genes 
up-regulated in response to oIFNT treatment to epithelial and fibroblast cells and were 
also up-regulated in endometrial explants in response a conceptus and IFNT [143].  
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